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Abstract
General synthesis of prostaglandins (PGs) has been accomplished based on a one-pot
three-component coupling using a combination of organocopper or organozincate
conjugate addition to 4-hydroxy-2-cyclopentenone followed by trapping of resulting
enolate with an organic halide. Based on the use of this synthetic methodology, biolog-
ically significant PG derivatives including ent-Δ7-PGA1, 15SAPNIC ([
3H]APNIC), and
15R–TIC have also been synthesized. Ultimately, organozincate conjugate addition com-
bined with the enolate trapping by an organic triflate results in practical green three-
component coupling comprising the use of stoichiometric amounts of three components
(enone, α- and ω-side chains in a nearly 1:1:1 ratio) without using HMPA and heavy
metals. General methodology for introducing short-lived 11C and 18F radionuclides into
carbon frameworks has been established by developing rapid C-[11C]methylation and
C-[18F]fluoromethylation using Pd0-mediated rapid cross-coupling between [11C]methyl
iodide and an organotributylstannane or organoboronate; or [18F]fluoromethyl bromide
and organoboronate, respectively, allowing the synthesis of a wide variety of biologi-
cally significant and disease-oriented PET probes such as 15R-[11C]TIC. Moreover, PdII-
mediated rapid C-[11C]carbonylation using [11C]CO and organoboronate at ambient
temperature under atmospheric pressure using conventional helium carrier gas has
been explored. Further, C-[11C]carboxylation has been promoted using [11C]CO2 and
organoboronate with RhI catalyst under atmospheric pressure.
Keywords: C-couplings, three-component PG synthesis, synthesis of biologically
significant PG derivatives such as ent-Δ7-PGA1, 15S–APNIC, and 15R–TIC, green
practical three-component coupling, general rapid 11C- and 18F-labelings, short-lived
PET probes, rapid C-[11C]methylations, rapid C-[18F]fluoromethylation, rapid C-[11C]
carbonylation, rapid C-[11C]carboxylation, human and environmental sciences
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1. Introduction
Organic synthesis has played a pivotal role so far in life science mainly by: (1) supplying
enough amounts of significantly biologically active molecules difficult to obtain from natural
sources; (2) enhancing the selectivity of biological activities as well as increasing chemical and
biological stabilities by the structural modification based on rational molecular designing. In
recent years, new research areas of “chemical biology” and “molecular imaging” have become
increasingly important, particularly by adding new trends in drug discovery and in imaging
diagnostics technologies. Accordingly, organic synthesis, with its huge potential in harmony
with such advancing interdisciplinary scientific areas are strongly demanded, particularly for:
(1) creating specific molecular probes to identify a target molecule (receptor) involved in the
mechanism of a biological activity; (2) and clarifying the behavior of molecules in in vivo
systems in terms of verifying drug efficacy and safety. In order to promote non-invasive
dynamic in vivo molecular science such as a PET study, many efforts to accelerate the rate of
the reaction are needed for labeling organic molecules with short-lived radioisotopes.
Described herein are highly polished and potentiated novel C-couplings developed by our
group in the course of long-term tight collaboration of chemistry, biology, and medicine [1–5].
2. Prostaglandin synthesis made easy by three-component coupling
Prostaglandins (PGs) exhibit diverse biological activities controlling a wide range of physiolog-
ical functions in the circulatory, respiratory, and digestive systems and are also involved in vital
defense processes such as inflammation, tissue repair, and immune response [6]. Although such
activities have attracted much attention in view of high potentials as therapeutic agents, the
supply of PGs from natural sources based on biosynthesis via PG-endoperoxide starting from
arachidonic acid (Scheme 1) is difficult [7]. Among chemical syntheses more than 450 reported
so far, Corey’s synthesis [7] is a great triumph in synthetic organic chemistry, allowing not only
commercial production but also contributing enormously to the progress of life science. The
process based on linear synthesis requires 17 steps and additional optical resolution for the
synthesis of PGF2α. The way to other PGs needs further additional steps. Obviously, “the three-
component coupling process,” namely the combination of three units, five-membered ring, α-
chain, and ω-chain to lead a whole PG framework, would be an ideal approach in view of
directness and synthetic flexibility (Scheme 2) [8]. Concretely, the three-component coupling
comprising the conjugate addition of metalated ω-side chain unit to the protected 4-hydroxy
2-cyclopentanone followed by electrophilic trapping of the resulting enolate intermediate by an
Scheme 1. Biosynthesis of prostaglandins.
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α-side chain of organic halide (Figure 1, route 1) had been planned for this purpose. However,
this convergent approach had been a long-lasting problem until our success (see the following
section) bcause the difficulty of controlling the enolate reactivity, namely the enolate, undergoes
the facile proton exchange during alkylation inducing dehydration as a major side reaction, and
eventually, decomposing to form a complex mixture (Figure 1, route 2) [8].
2.1. Highly selective mono-methylation of cyclopentanone lithium enolate with methyl
iodide
Cyclopentanone lithium enolate (1) tends to undergo polyalkylation in THF without additives
(Table 1, Entry 1), and therefore, this enolate was chosen as a model for realizing controlled
mono-alkylation with an alkyl halide (Table 1). Thus, clean mono-alkylation of the lithium
enolate with methyl iodide has been established in the combination of (C6H5)3SnCl (1 equiv)
and HMPA (5 equiv) as additives at 30C for 6 h to give 1-methylcyclopentanone with 77%
yield (Entry 3) [9]. The combination of (CH3)2Zn (1 equiv) and HMPA as additive is also
efficient; the reaction at 78C for 20 h, gives the same product with 95% yield (Entry 4) [10].
Here, HMPA accelerates the reaction (Entry 2) [10, 11] and (C6H5)3SnCl or (CH3)2Zn
suppresses the polyalkylation. Notably, it was proven that the reactive species is HMPA-
coordinated lithium enolate and that LiI is not involved in the reaction.
2.2. Extremely short-step synthesis of PGE2 by three-component coupling
The conditions thus obtained have successively being applied to the synthesis of PGE2 (6)
(Scheme 3), realizing the three-component coupling synthesis of PGs (via direct alkylation
Scheme 2. Chemical synthesis (three-component synthesis, a long-lasting problem in synthetic chemistry).
Figure 1. Problems of the three-component prostaglandin synthesis.
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route) for the first time. Here, the conjugate addition was performed by using the newly
devised organocopper reagent [12] and the protected (R)-4-hydroxy-2-cyclopentanone (2) at
1:1 ratio in order to avoid the presence of extra nucleophiles in the reaction system. The
combination of this conjugate addition and the trapping of the resulting metalated enolate
with an excess amount of α-side chain iodide (4) in the presence of HMPA and (C6H5)3SnCl led
to the successful construction of a whole PG skeleton [9, 13]. Thus, the metalated ω-side chain
(3) was prepared in situ by treating the corresponding ω-side chain iodide with tert-C4H9Li (2
equiv) followed by the addition of CuI-(n-C4H9)3P (1:2.6 equiv ratio) at 78
C in THF. After
conjugate addition to (2) at 78C in THF, the resulting metalated enolate was quenched by α-
side chain allyl iodide (4) (5 equiv) in the presence of HMPA (5 equiv) and (C6H5)3SnCl (1
equiv) at30 to20C for 39 h in THF to give the desired coupling product (5)with 78% yield.
Subsequent deprotection followed by ester hydrolysis afforded PGE2 (6) at 83% yield.
2.3. General synthesis of prostaglandins
The alkylation of the enolate intermediate generated by the conjugate addition using a stoi-
chiometric amount of the organocopper phosphine complex [12] with (2) at 78C in THF
with methyl 7-iodo-5-heptynylate (7, 5 equiv) in the presence of HMPA (11 equiv) and
(C6H5)3SnCl (1 equiv) in THF at 30
C for 39 h gives 5,6-dehydro-PGE2 methyl ester (8) at
76% yield (Scheme 4, Conditions A) [13]. It was found that the conjugate addition proceeds by
using triorganozincate species generated by a 1:1 mixing of ω-side chain lithium and (CH3)2Zn
OLi
+ CH3I
O
CH3
O
CH3H3C
O
H3C
CH3
CH3
O
CH3
CH3
O
CH3
CH3H3C
H3C
additives
THF
++
++
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Yield, %
Entry CH3X (equiv) Additives (equiv) Temp.,
C Time, h Monoalkyl ketone Polyalkyl ketone
1 CH3I (5) — 0 1 51 33
2 CH3I (5) HMPA (5) 78 20 95 3
3 CH3I (5) (C6H5)3SnCl (1), HMPA (5) 30 6 77 0
4 CH3I (5) (CH3)2Zn (1), HMPA (5) 78 20 95 0
5 CH3OTf (1.2) — 78 1 98 2
6 CH3OTf (1.2) (CH3)2Zn (1) 78 2 100 0
7 CH3OTf (1.2) (CH3)2Zn (3) 78 2 100 0
Table 1. Highly selective mono-methylation of cyclopentanone lithium enolate with methyl iodide.
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without a transition metal [10, 14]. Similarly, the coupling of the enolate thus prepared by the
conjugate addition with propargylic iodide (7, 5 equiv) in the presence of HMPA (10 equiv) in
THF at 78 to 40C for 24 h, after workup and chromatographic separation, gives (8) at 71%
yield (Scheme 4, Conditions B). The isolation of the product in latter process is much easier
than the former. General syntheses of PGs have been accomplished via the propargylic inter-
mediate (8) in several steps including selective hydrogenation leading to PGE1, PGE2, PGF1α,
and PGF2α in addition to Pd
II-mediated intramolecular cyclization of a hydroxyl group at the
C(9) to the C(7) positions, respectively, followed by depalladation with ammonium formate to
generate prostacyclin (PGI2) in an extremely short way (Figure 2) [14, 15].
The enolate species in situ prepared by the conjugate addition of an ω-side chain to (2) can also
be trapped by other electrophiles such as α-chain aldehyde [16] and nitro-olefin, [17] to
synthesize PGs and biologically significant PG analogs such as Δ7-PGA1 (9), [18] ent-Δ
7-PGA1
(10), [19] and 6-oxo-PGE1 (11) [17].
Scheme 4. Synthesis of 5,6-dehydro PGE2 methyl ester (8).
Scheme 3. Extremely short-step synthesis of prostaglandin E2 (6) by three-component coupling.
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2.4. Synthesis of isocarbacyclin
Isocarbacyclin (12), a stable analog of the chemically unstable PGI2, created synthetically by
Ikegami [20] has potent PGI2 like activities. The structure is featured by the olefinic bond at C
(6) and C(9α) positions in the bicyclo[3,3,0]octane skeleton. Our synthetic plan to introducing
this structure stems on radical cyclization between carbons at the C(9α) and C(6) positions by
5-exo-dig manner and subsequent γ-protodesilylation of an allylsilane (Scheme 5) [21] The
accomplished synthetic route is illustrated in Scheme 6. Thus, starting from the acetylenic
intermediate (8), sequencing reactions of methylenation of the carbonyl at C(9) position gives
(13) stereoselective hydroboration, followed by H2O2 oxidation giving (14), pyridinium dichro-
mate (PDC) oxidation, and silylation giving the silyl alcohol (15). After conversion to m-
(trifluoromethyl) benzoate, photolysis gave the allylsilane (16) with 1:1 stereoisomeric mix-
tures, and then treated with aqueous HClO4 for deprotection and CF3COOH for protodesi-
lylation to give isocarbacyclin methyl ester (17) regiospecifically, which undergoes hydrolysis
facilely to afford isocarbacyclin (12).
Figure 2. General syntheses of prostaglandins.
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2.4.1. Synthesis of azide-functionalized isocarbacyclin analog, 15S–APNIC and radio-labeled
photoaffinity probe, 15S-[3H]APNIC for identification of a prostacyclin receptor (IP)
Prostacyclin (PGI2) is particularly a potent vasodilator and an inhibitor of platelets aggregation
among PGs. It activates adenylate cyclase in platelets, vascular smooth muscles, NCB-20 cells,
and mastocytoma-p-815 cells. However, there has been little progress in the study of the
structure of the PGI2 receptor protein (IP) because of its low concentration in cell membranes
and the lack of a suitable antagonist making it difficult to solubilize the receptor protein to a
homogeneous state without loss of the binding activity. Here, we have been intrigued by the
use of a photoaffinity labeling method as another tool for the identification of the receptor
RO OR
R3Si
COOCH3
HO
COOH
OH
isocarbacyclin (12)
HO
COOCH3
OH
R3Si 69a
Scheme 5. Strategy for regiospecific construction of cyclopentenone structure in isocarbacyclin (12).
Scheme 6. Synthesis of isocarbacyclin methyl ester (17).
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protein. A novel molecular probe for this purpose has been designed and synthesized as follows
(Scheme 7, route A) [22]: the ω-side chain in isocarbacyclin methyl ester (17) was readily
degraded by selective epoxidation of an allylic olefin with Sharpless method followed by the
epoxide ring opening and subsequent NaIO4 oxidation to give the aldehyde (18), which further
underwent the carbon elongation to reconstruct the PG skeleton by Horner-Emmons type con-
densation with the azide-functionalized phosphonate (19), resulting in affording the enone (20).
The reduction of the carbonyl in (20) using NaBH4 in the presence of CeCl3 gives allylic alcohol
in a 1:1 diastereomeric mixture, which can be separated by silica gel chromatography to afford
pure esters of azide-functionalized isocarbacyclin analogs, APNIC methyl esters (21a) and (21b)
as more and less polar materials, respectively. Here, S- and R-configurations at the C(15) position
of these diastereoisomers were determined by chemical transformations from methyl ester of
APNIC (15S-APNIC methyl ester) and defined optically active by (S)-glycerol 1,2-acetonide,
respectively to give the same (S)-2-hydroxy-6-phenylhexanol [22]. Finally, each ester underwent
alkali hydrolysis, giving (15S)-22a and (15R)-22b, respectively. The tritium labeled 15S-APNIC
([3H]-(15S)-22a) is prepared commercially (Amersham International in England) under the same
reduction conditions using [3H]NaBH4 with CeCl3, followed by alkali hydrolysis.
The aldehyde intermediate (18) can also be prepared by deprotection (CH3COOH/H2O/THF)
of the corresponding THP-protected aldehyde compound [23] derived from Corey lactone [7].
Results of binding assay [22, 24]: (15S)-22a has the highest affinity among the azidophenyl
derivatives and exhibited an IC50 value of 3 nM (Figure 3).
Scheme 7. Synthesis of stable prostaglandin I2 analogs, 15S-APNIC ((15S)-22a) and 15R-TIC ((15R)-27b).
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Biological activity (Figure 4) [22, 24]: the activity study of (15S)-22a as an agonist on the stimu-
lation of adenylate cyclase in the mastocytoma P-815 membrane fraction using iloprost (23) as a
standard compound exhibited that the half-maximal concentration to stimulation was 50 nM,
convincing us that (15S)-22a has considerable agonist character for the PGI2 receptor (IP).
Identification of IP (Figure 5) [24]: photoaffinity labeling of the PGI2 receptor was conducted
by UV irradiation using the membranes of porcine platelets with [3H]-(15S)-22a, followed by
SDS-PAGE to give the results shown in Figure 5—the left panel shows radioactivity in the gel
slice; the right, fluorography, lane1 ([3H]-(15S)-22a only), lane 2 (in the presence of GTPγS),
lane 3 (in the presence of (23)). Thus, photoaffinity labeling entraps a 45 kDa protein in porcine
platelets membranes. The protein is also sensitive to GTPγS and the binding [3H]-(15S)-22a is
blocked by iloprost.
2.4.1.1. Synthesis of tolyl-functionalized isocarbacyclin analog, 15R–TIC, a ligand specifically
binding with novel prostacyclin receptor subtype (IP2) in the central nervous system
Several lines of evidence suggest that PGI2 also has neuromodulatory actions. A quantitative
in vitro autoradiographic mapping of the PGI2 receptor in the brain using a stable specific
agonist for a PGI2 receptor demonstrated a high density distribution in four regions of the
lower brain stem including the medial and commissural subnuclei of the nucleous tractus
solitarius (NTS). Precise analysis of the role of PGI2 in the brain requires the development of a
specific molecular probe capable of sharply discriminating the actions in the central and
peripheral nervous systems, respectively. In this context, our interest has been directed toward
designing a new ligand selectively responsive to a receptor in the central nervous system [1].
Thus, the title compound 15R-TIC specifically binding with a novel PGI2 receptor in the central
nervous system has been devised as follows [25]: the steps are similar to the synthetic scheme
of APNIC as shown in route B (Scheme 7); the Horner-Emmons type condensation of (18) with
Figure 3. Binding affinity with a PGI2 receptor: Displacement of [
3H]iloprost by azidophenyl derivatives ((15S)-22a,
(15R)-22b) vs. iloprost (23).
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the phosphate (24) to elongate the carbon chain gives the enone (25) and subsequent reduction
in the presence of CeCl3 gives the diol with a 1:1 mixture of diastereomers at the C(15) position.
The stereoisomers are separated by silica gel chromatography to give stereochemically pure
alcohols, 26a and 26b, as different polarities on TLC (Rf = 0.18 and 0.26 with 1:1 ethyl acetate
Figure 4. Effect of iloprost (23) and 15S–APNIC ((15S)-22a) on adenylate cyclase activity in the presence of GTP.
Figure 5. Photoaffinity labeling of the membrane of porcine platelets with [3H]APNIC. A 45-kDa protein was labeled by
photolysis in the presence of [3H]APNIC ([3H]-(15S)-22a). Porcine platelet membranes were incubated with [3H]APNIC in
the absence (lane 1) or presence of GTPγS (lane 2) or iloprost (23) (lane 3).
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and hexane as solvent), respectively. Finally, alkali hydrolysis of 26a and 26b affords the
corresponding tolyl-functionalized isocarbacyclin analogs, 15S–TIC ((15S)-27a) and 15R–TIC
((15R)-27b), respectively. The configuration of the carbon center at the C(15) position is deter-
mined by chemical transformations similar to that in the synthesis of APNIC starting from
(26a) and optically active (S)-glycerol 1,2-acetonide (30) to give the same tolyl-containing bis
(MTPA)ester (29) (Scheme 8).
The binding assay for PGI2 receptor proteins in frozen tissue sections containing either the
thalamus or the NTS as representative of the central or peripheral nervous systems, respec-
tively, was conducted by the replacement of 10 nM tritium-labeled isocarbacyclin ([3H]
isocarbacyclin) with nonradioactive derivatives as shown in Figure 6 [26]. It was discovered
that 15R–TIC ((15R)-27b), which exhibited the highest binding affinity for the receptor in the
thalamus (IC50 = 31 nM) among other TIC derivatives, showed very weak binding with the
receptor in NTS (IC50 = 1 μM). The 15S isomer (15S)-27a showed slightly lower binding
(IC50 = 38 nM) in the thalamus than (15R)-27b and maintains considerably strong binding
affinity (IC50 = 32 nM) in the NTS. Other TIC derivatives showed weaker thalamus binding
affinity. Isocarbacyclin (12), a lead compound for the study, exhibited high binding affinity
both in the thalamus (IC50 = 31 nM) and the NTS (IC50 = 23 nM). The binding profile of 15R–
TIC ((15R)-27b) distinctly contrasted with that of cicaprost (32), a stable PGI2 receptor agonist
in the iloprost family, which showed high binding and selectivity for the receptor in the NTS
(IC50 = 30 nM). Consistent with the binding property, 15R–TIC showed a very weak inhibitory
effect on platelets aggregation (IC50 > 400 nM), while cicaprost (32) and isocarbacyclin (12)
exhibited potent inhibitory effects (IC50 = 3.2 and 2.5 nM, respectively). Thus, we succeeded in
Scheme 8. Determination of the absolute configuration at C(15) of the isocarbacyclin analog by chemical correlation.
Green Process of Three-Component Prostaglandin Synthesis and Rapid 11C Labelings for Short-Lived…
http://dx.doi.org/10.5772/intechopen.72868
11
finding a stable PGI2 analog with high binding selectivity for the PGI2 receptor (IP2) in the
central nervous system based on the structural modification of isocarbacyclin (12) [1, 25, 26]. In
addition, later, 15-deoxy-TIC (33) with a binding potency for IP2 ten times higher than 15R–
TIC ((15R)-27b) and a weak inhibitory effect on platelet aggregation (IC50 > 400 nM) has been
synthesized by the stepwise construction of the E-olefin structure in the ω-side chain [27]. Both
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Figure 6. Binding studies of 15R–TIC ((15R)-27b) for PGI2 receptors in the central nervous system (IP2) and the peripheral
system (IP1). Displacement of 10 nM [
3H]isocarbacyclin ([3H]-12) binding by nonradioactive 15R–TIC ((15R)-27b, ●),
isocarbacyclin (12, ■), and cicaprost (32, ▲) in thalamus (A) and the NTS (B) of frozen sections of rat brain A and
thalamus B. NTS: Nucleus tractus solitaries.
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15R–TIC ((15R)-27b) and 15-deoxy TIC (33) showed distinct protective effect for hippocampal
neuronal death under high oxygen (50%) atmosphere [28]. Such an anti-apoptotic effect was
more potent than basic fibroblast growth factor (bFGF) at its maximum values. Here, (33) was
about ten times more potent in the neuronal protection than (15R)-27b (IC50 = 30 and 300 nM,
respectively), being in good correlation to their binding affinities for the IP2 receptor [25, 26].
Furthermore, (15R)-27b strongly protected CA1 pyramidal neurons against ischemic damage
in gerbils; thus, we can conclude that (15R)-27b acts as an effective neuronal survival-
promoting factor both in vitro and in vivo vital systems [29]. To perform in vitro analyses of
TICs, tritium-labeled TIC was needed. Thus, the tritium labeling of TICs, a mixture of 15S-[3H]
TIC ([3H]-(15S)-27a) and 15R-[3H]TIC ([3H]-(15R)-27b), was conducted using commercial ser-
vice (Amersham International in England) according to the same reduction scheme as
described using [3H]NaBH4 with CeCl3. It was then followed by alkali hydrolysis and
reverse-phase HPLC separation into pure forms. The binding sites using [3H]-(15R)-27b for a
number of coronal sections of rat brain indicated that the binding was high in most of the
thalamic regions, limbic structures, and some parts of the cortical regions [26]. The binding of
[3H]-(15R)-27b was displaced by 15R–TIC ((15R)-27b) efficiently (IC50 = ca. 10 nM)). The
Scatchard analysis in rat brain sections using [3H]-(15R)-27b showed that there were two
binding sites with high and medium-high affinities for the IP2 in the thalamus and striatum;
the Kd values were 0.94 and 30 nM in the thalamus, and 0.54 and 37 nM in the striatum,
respectively [26]. It was also found that the CNS-specific PGI2 receptor (IP2) was expressed
mainly in neurons, but not in the presynaptic terminals of afferents or glial cells [26].
With regard to the influence of the length of the ω-side chain in TICs, we found that the
binding affinity for the PNS-type PGI2 receptor (so called IP; here IP1) in the NTS increased in
the order of: 16-m (n = 1) < 17-p (n = 2), 19-p (n = 4) < 17-m (n = 2) < 19-m (n = 4), while for the
CNS-specific PGI2 receptor (referred to as IP2) in the thalamus, it increased in the order of: 19-m,
19-p (n = 4) < < 17-p (n = 2) < 17-m (n = 2) < 16-m (n = 1) [25, 26]. Thus, the receptor in the NTS
favors longer side-chain derivatives, while the receptor in the thalamus matches more with
shorter chain analogs. In both cases, the meta-methyl substituent on the aromatic ring was
preferred. Overall, (15R)-27b exhibited the highest binding affinity for the CNS-specific PGI2
receptor (IP2) in the thalamus. It is also worth noting that the binding tendency obtained for
the PNS-type PGI2 receptor (IP1) in the NTS is consistent with the binding mode of 15S–
APNIC ((15S)-22a) for the PGI2 receptor (IP) in mast cells and platelets as peripheral systems
shown in the previous section [22]. The tolyl structure in (15R)-27b here was designed so that it
could be used for in vivo molecular imaging study on the novel prostacyclin receptor subtype
(IP2) in the living brain after introduction of a short-lived
11C radioisotope in the methyl group
(see Section 3.1.2).
2.5. Ultimately clean three-component coupling using nearly stoichiometric amounts (1:1:1
ratio) of (R)-4-hydroxy-2-cyclopentanone, and α- and ω-side chains without using heavy
metals and carcinogenic HMPA: Realization of practical green coupling process
The decreasing amounts of α-side chain unit and hazardous HMPA in our three-component
coupling is important to realize an ideal stoichiometric green process (see Scheme 4 and
Figure 2 in Sections 2.3 and 2.4). In this context, Gooding devised a two-step sequential
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process [30]: The trapping of the enolate species, generated by the conjugate addition of the ω-
side chain vinyl lithium obtained from (34) in the presence of Li2(CH3)2Cu(CN) to get enone
(35); reaction with trimethylsilyl chloride to synthesize the enol silyl ether (36); then the crude
(36) is treated again with n-butyl lithium to generate pure lithium enolate, which undergoes
alkylation with methyl 5,6-dehydro-7-triflyl-heptenoate ((37), 1.7 equiv) to give 5,6-dehydro-
PGE2 methyl ester (38) at 65% yield (Scheme 9). Based on this information, Lipshutz tried a
one-pot synthesis of the whole skeleton of the PG by conjugate addition of the ω-side chain
nucleophile generated by the treatment of the zirconylated ω-side chain unit in the presence of
CH3Li, Li2(CH3)2Cu(CN), and (CH3)3ZnLi to give (35), followed by alkylation of the enolate
intermediate with an excess amount of the same triflate (37, 6.0 equiv) to give 5,6-dehydro-
PGE2 methyl ester (40) as a stereoisomeric mixture (15) at 71% yield (Scheme 10) [31]. The
need for an excess amount of α-chain triflate (37) to trap the enolate is presumably due to the
complicated character of the enolate system including a transition metal after conjugate addi-
tion—there is still potential for further exploration. As shown in Table 1 (continued) (see also
Table 1 in Section 2.1), interestingly, the trapping of the lithium enolate with methyl triflate in
THF gave mono-methylation in 98% accompanied with 2% of polyalkylation product (Entry 5).
 
 
(n-C4H9)3Sn
O
TBSO
COOCH3
OTBS
OTBS
(H3C)3SiO
TBSO OTBS 34
36, Once isolation, then next reaction
a. 34, Li2(CH3)2Cu(CN)
a. n-C4H9Li
b. RaOTf (37, 1.7 equiv)
38, 65%
O
TBSO
35
RaOTf =
37
COOCH3TfO
b. TMSCl, Et3N
TBS = tert-butyldimethylsilyl
THF
Scheme 9. Two-step protocol for the synthesis of a prostaglandin intermediate based on the alkylation of lithium enolate
with propargylic triflate.
Scheme 10. One-pot three-component coupling based on the conjugate addition followed by enolate alkylation with an
excess amount of propargylic triflate.
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- On the other hand, surprisingly, in the presence of dimethylzinc (1 to 3 equiv), the reaction gave
onlymono-methylation in quantitative yield as determined by GC analysis (Entries 6 and 7) [32].
These facts mean that the addition of dimethylzinc to the lithium enolate system completely
suppresses the proton exchange causing polyalkylation; the reaction system still has enough
reactivity for alkylation with methyl triflate even in the absence of HMPA. These fascinating
findings reminded us of the combination with organozinc-aided conjugate addition previously
developed by our group [10, 14] (see Section 2.3). Thus, a one-pot operation conducted by the
conjugate addition of protected (R)-4-hydroxy 2-cyclopentanone (2) by ω-side chain vinyl lith-
ium generated from vinyl stannane (34) (1 equiv) in the presence of 1 equiv of dimethylzincin
THF at 85C for 1.5 h followed by trapping of the resulting enolate with propargyl triflate (37)
prepared by the corresponding alcohol (1.5 equiv for (2)) at 78C for 2 h gave the protected
5,6-dehydro-PGE2 methyl ester (8) at a high yield of 88% (Scheme 11, A) [32], which is a key
intermediate for general synthesis of natural PGs (see Figure 2 in Section 2.3) and isocarbacyclin
(12) (see Scheme 6), whose methyl ester (17) can also lead to 15S–APNIC ((15S)-22a) and 15R–
TIC ((15R)-27b) via the ω-side chain manipulation (see Sections 2.4.1.1 and 2.4.1.2). Most likely,
the combination of the conjugate addition of ω-side chain lithium dimethylzincate generated by
an ω-side chain lithium (generated from (41) with n-butyllithium in THF at 78C, 1 h) and
A
B
 
C
O
TBDMSO
O
TBDMSO
COOCH3
a. 34/n-C4H9Li, (CH3)2Zn
2
b. RaOTf  (37, prepared
8, 88%
from 1.5 equiv of the 
corresponding alcohol)
–78 °C, 2 h
THF, –85 °C, 1.5 h
TBDMSO
natural PGs and 12
O
TBDMSO
(n-C4H9)3Sn
O
TBDMSO
COOCH3
TBDMSO
TBDMSO
CH3
CH3
a. 41/n-C4H9Li, (CH3)2Zn
2
b. RaOTf  (37, prepared
 42, 79%
41
from 1.5 equiv of the 
corresponding alcohol)
–78 °C, 1 h
THF, –90 °C, 30 min
44, 86%
O
TBDMSO
(n-C4H9)3Sn
O
TBDMSO
COOCH3
CH3
CH3
a. 43/n-C4H9Li, (CH3)2Zn
2
b. RaOTf  (37, prepared
43
from 1.5 equiv of the 
corresponding alcohol)
–78 °C, 1 h
THF, –90 °C, 30 min
Scheme 11. Ultimate one-pot three component coupling comprising organozincate conjugate addition (1:1 ratio of ω-side
chain and the enone) followed by alkylation of the resulting enolate with nearly stoichiometric amounts of the α-side
chain propargyl triflate. A: three-component coupling using natural ω-side chain unit leading to a key intermediate for
general synthesis of natural PGs and isocarbacyclin (12); B: three-component coupling using unnatural ω-side chain unit,
potentially useful for the synthesis of 15R–TIC ((15R)-27b); C: three-component coupling potentially useful for the
synthesis of 15-deoxy-TIC (33).
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dimethylzinc (1 equiv) to the enone (2) at 90C for 30 min followed by the trapping of the
enolate with α-side chain triflate (37) (prepared from 1.5 equiv corresponding alcohol) at 78C
for 1 h gave the desired coupling product (42) at 79% yield (Scheme 11, B) [32]. Further, the
combination of the conjugate addition of ω-side chain derived from (43) followed by trapping
with (37) also gave (44) at 86% yield (Scheme 11, C) [32]. The latter two products, (42) and (44),
are potentially key intermediates for the straightforward synthesis of 15R–TIC ((15R)-27b) and
15-deoxy-TIC (33), respectively (see Sections 2.4, 2.4.1.2, and 3.1.2). Thus, we succeeded in
realizing an ultimate one-pot three-component coupling process called green coupling process
based on a novel organozinc-aided conjugate addition/alkylation using stoichiometric amounts
(nearly 1:1:1 ratio) of enone, and α- and ω-side chain units without using heavy metals and
carcinogenic HMPA.
3. Efficient synthesis of short-lived 11C- and 18F-labeled PET probes by
Pd0-mediated rapid cross-coupling reactions, C-[11C]methylation, C-[18F]
fluoromethylation, C-[11C]carbonylation, and C-[11C]carboxylation
Positron emission tomography (PET) is a noninvasive imaging technology with good resolu-
tion, high sensitivity, and accurate quantification, that assists in temporally and spatially
analyzing the dynamic behavior of molecules in in vivo systems using a target-specific molec-
ular probe labeled with positron-emitting radionuclides such as 11C, 13N, 18F, and 76Br
(Figure 7) [33]. As shown in Figure 7, a positron (positively charged electron, e+) emitted by a
radionuclide collides with a nearby electron within a few millimeters inside the tissue to
produce two high-energy γ-ray photons of 511 keV each. These photons travel in opposite
directions (at 180) in the body and can be detected by a pair of opposing scintillation
Figure 7. Principle of brain imaging by PET representatively shown by 11C to 11B decay.
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he detectors. If the two opposite detectors are hit by the positrons simultaneously, it indicates that
the photons come from the same decay event. The data are then fed to a computer that
reconstructs the three-dimensional tomographic image of the sample being analyzed. PET
enables in vivo imaging using an extremely small mass of the compound (sub-femtomole), at
extremely low concentrations (sub-picomolar) far below the critical concentration that would
cause pharmacological effects. The advantages of PET technology include the following: (1) O,
N, and C are ubiquitous elements in biologically active compounds occurring in nature; (2)
high resolution and sensitivity; (3) a short half-life that makes it safe even with radiation
exposure. Thus, PET has been extensively used for the diagnosis of various diseases as well as
in drug discovery processes, particularly in human microdosing trials during the early stage of
drug development (see also Section 5) [34, 35]. The potential applications of PET molecular
imaging in an interdisciplinary scientific area strongly depend on the availability of suitable
radioactive molecular probes with specific biological functions. The development of biologi-
cally significant and novel PET probes can be accomplished by combining an efficient syn-
thetic strategy for designing molecules and new advances in the field of labeling chemistry
[36]. Among the short-lived positron-emitting radionuclides, 11C and 18F, with a half-life of
20.4 and 109.8 min, respectively, have often been used for radiolabeling because they are the
most significant radionuclides from both a chemical and biological perspective. These 11C and
18F-labeled precursors can be synthesized via nuclear reaction as shown in Figure 8.
Need for rapid reactions for 11C-labeling: Certain aspects of PET radiochemistry such as short half-
lives, extremely small amounts of available radionuclides, and relatively high-energy radia-
tion, impose severe restrictions on the synthesis of PET probes. In particular, the synthesis of a
pure, injectable 11C-labeled probe must be accomplished within a maximum of two to three
half-lives (i.e., 40–60min) because of its rapidly decaying radioactivity. The synthetic processes
include: (1) preparation of a standard radiolabeled precursor such as [11C]CH4, [
11C]CH3I,
[11C]CH3OTf, [
11C]CO, and [11C]CO2 based on the nuclear reaction
14N(p,α)11C; (2) 11C-
labeling the synthesis of the target PET probe (see also Figure 8); (3) work-up and
B
A
Figure 8. Production of 11C and 18F precursors from nuclear reaction. A. Preparation of [11C] carbon dioxide, [11C] carbon
monoxide, and [11C] methyl iodide as 11C-precursors; B. Preparation of [18F] fluoride ion.
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chromatographic purification; and (4) preparation of an injectable solution for an animal/
human PET study (pharmaceutical formulation). Thus, the time allowed for a 11C-labeling
reaction should be less than 5 min, inevitably necessitating a rapid chemical reaction. Another
limitation encountered in the synthesis of a 11C-labeled PET probe is the extremely small
amounts (normally nanomol level) of the 11C-labeling precursors such as [11C]CH3I. Therefore,
the labeling reaction is usually carried out with a larger amount (several milligrams) of the
reacting substrate (micromol level) to conduct the reaction conveniently. A PET probe thus
obtained must be highly pure; the PET probe for clinical use should be synthesized at the Good
Manufacturing Practice (GMP) level according to the regulation guidelines (also see Section 5).
Toward general 11C-labelings, four types of rapid C-[11C]methylations: In PET radiochemistry, the
[11C]methylation of hetero-atoms such as N, O, and S has mainly been explored because of its
simple reaction conditions wherein [11C]CH3I is mixed with a large amount of the substrate.
However, a carbon-hetero-atom bond tends to be metabolized to produce [11C]CH3OH, [
11C]
CH2O, and H[
11C]COOH, which are dispersed over the entire organ, thus decreasing the
credibility of the PET image. In this study, we considered employing [11C]methylation via the
Cd11C bond formation (referred to as C-[11C]methylation) [3, 4] as it has a number of advan-
tages: (1) the [11C]methyl group attached to the C atom is much more stable metabolically, thus
providing a highly credible PET image; (2) a methyl group is the smallest non-polar substitu-
ent with the least influence on the parent biological activity; (3) short half-lived 11C is favorable
to rapidly screen optimized reaction conditions and ready evaluation of in vivo behavior
allows several trials per day. These attractive features and benefits prompted us to investigate
the realization of four types of rapid C-[11C]methylations on organic frameworks involving
arene, alkene, alkyne, and alkane, namely cross-coupling reactions between sp2 (aryl) and sp3
(alkyl) hybridized carbons, sp2 (alkenyl) and sp3 (alkyl) carbons, sp (alkynyl) and sp3 (alkyl)
carbons, and sp3 (alkyl) and sp3 (alkyl) carbons (Figure 9). This allowed us to validate the 11C-
labeling of the entire range of organic compounds. Subsequent pharmacokinetic (PK)/pharma-
codynamics (PD) studies in in vivo systems using PET could offer a new methodology to
Figure 9. Four types of rapid C-[11C]methylations and their benefits.
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animal/ promote “evidence-based medicines” at the molecular level. The use of moisture-sensitive
organolithium compound for this purpose could not justify the stoichiometry of an extremely
small amount of [11C]CH3I, resulting in the unavoidable production of a large amount of an
undesired demethylated derivative due to the use of an excess amount of the lithiated sub-
strate together with the formation of undesired side reactions under such drastic conditions
[37]. Accordingly, the tedious work to remove the demethylated side products is obliged to be
done for obtaining the desired 11C-labeled compound with high purity.
Benefits and problems of organostannanes as trapping substrates: The Stille reaction was considered
as the first choice for this purpose (synthesis of PET probes using [11C]CH3I) because of the
favorable properties of organostannanes [38] (organotin compounds): (1) easy preparation via
a number of synthetic routes even when they contain a variety of reactive functional groups;
(2) organostannanes are not particularly oxygen or moisture sensitive; (3) high tolerance to
various chemical reactions and chromatographic purification conditions, enabling the incor-
poration of a radioisotope in the final or close to the final step; (4) extremely low polarity that
allows an easy separation of the desired product from the substantial remaining tin substrate
after labeling reaction. However, the Stille reaction was rarely used with methyl iodide as an
sp3-hybridized carbon partner, compared to its wide applicability to aryl or allyl halides with
sp2- or sp3-hybridized carbons; it is rather difficult to realize methylation in high yields.
Actually, the Stille group reported that the reaction of CH3I and p-methoxyphenyltributyl-
stannane in the presence of [Pd{P(C6H5)3}4] at 50
C for 24 h induced a scrambling reaction
between the methyl and phenyl groups in the methyl iodide and triphenylphosphine, respec-
tively, affording the desired p-methoxytoluene at only 3% yield along with undesired 1-
methoxy-4-phenylbenzene as a byproduct at 8% yield [39]. The use of more reactive phenyltri-
methylstannane as the substrate also induces competition between [11C]CH3 in [
11C]CH3I and
CH3 and phenyl groups in the stannane to produce [
11C]CH3CH3 and non-radioactive
C6H5CH3 as byproducts (also see Section 3.1.1) [40]. In this study, we have considered devising
new reaction conditions that are capable of promoting a rapid cross-coupling reaction.
3.1. Exploration of four kinds of rapid C-[11C]methylations
3.1.1. Optimized conditions to promote the rapid reaction of methyl iodide with an excess amount of
phenyltributylstannane (rapid coupling between sp2(aryl)-sp3 hybridized carbons)
Keeping in mind the 11C radiolabeling conditions for a PET probe synthesis, we set up a model
reaction using methyl iodide and an excess amount of phenyltributylstannane (45) ([CH3I]/
[45] = 1:40 in molar ratio) to possibly reduce the reaction time to less than 5 min (Table 2) [40].
The yield of the methylated product, toluene (46), was determined based on the CH3I
consumption. As expected, the conventional Stille reaction conditions with a reaction time
of 30 min did not afford the desired product (Table 2, Entry 1), leading us to introduce the
concept of coordinative unsaturation to activate the Pd catalyst. Thus, we found that the
use of a coordinatively unsaturated Pd0 complex, [Pd{P(o-CH3C6H4)3}2] [41], generated in
situ by mixing [Pd2(dba)3] and sterically bulky tri-o-tolylphosphine (cone angle = 194
 for
P(o-CH3C6H4)3) [42] instead of triphenylphosphine (cone angle = 145
 for P(C6H5)3) [42],
significantly increased the yield (76%, Entry 2). Next, we introduced an additional concept to
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shorten the reaction time (from 30min to 5 min). Because simple heating (80C) was less effective
and lowered the yield, we stabilized the transiently formed Pd catalyst using DMF; this effec-
tively increased the yield to a considerable extent (Entry 4). Furthermore, we tried to enhance the
reaction rate by adding a CuI salt, expecting Sn to Cu transmetallation, and K2CO3 to react with
the (n-C4H9)3SnX (X = I and/or Cl) byproduct generated during the reaction to neutralize the
reaction mixture. Thus, the reaction of the CH3I/45/[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 sys-
tem (1:40:0.5:2:2:2) in DMF at 60C for 5 min affords the desired product at 91% yield (Table 2,
Entry 5) [40]. It should be noted that the reaction using phenyltrimethylstannane affords (46) at
122–129% yield because of ethane impurity, indicating the undesired cross-coupling reactions
(scrambling) between the CH3 groups in CH3I and those on the tin atom (phenyltrimethyl-
stannane). Such a reaction between [11C]CH3I and phenyltrimethylstannane under PET radio-
labeling conditions produce undesired radioactive and volatile ethane, [11C]CH3CH3. The
product from the scrambling reaction between the phenyl and methyl groups on the tin atom
also contaminate toluene (the undesired product in the actual PET probe synthesis) to a signifi-
cant extent [40], decreasing the yield of the desired [11C](46); thereby reducing the molar activity
[43]. These phenomena were also reported during the Pd-catalyzed reaction of 1-(20-deoxy-20-
fluoro-β-D-arabinofuranosyl)-5-(trimethylstannyl)uracil to synthesize [11C]FMAU [44]. There-
fore, we concluded that phenyltributylstannane, although less reactive, would serve as a much
more suitable coupling partner than phenyltrimethylstannane because of the increased yield of
the reaction, radiation safety and relatively low toxicity: it should be noted that tributyltin
derivative is practically non-toxic, while trimethyltin has a significant acute toxicity [45].
The reaction conditions thus discovered are significantly different from those of the originally
reported Stille coupling. The rapid coupling of CH3I and (45) probably proceeds by the
mechanism proposed in Eqs. 1–5 [40].
 
CH3I +
Sn(n-C4H9)3
Pd0 complex
Solvent (1 mL)
CH3
6454 (400 mmol)
additives
(10 mmol)
Entry Pd0 complex (μmol) Ligand (L) and/or additive (μmol) Solvent Temp., C Time, min Yield, %
1 [Pd{P(C6H5)3}4] (10) — DMSO 40 30 0
2 [Pd2(dba)3] (5) P(o-CH3C6H4)3 (20) DME 40 30 76
3 [Pd2(dba)3] (5) P(o-CH3C6H4)3 (20) DME 80 5 41
4 [Pd2(dba)3] (5) P(o-CH3C6H4)3 (20) DMF 80 5 63
5 [Pd2(dba)3] (5) P(o-CH3C6H4)3 (20),
CuI (20)
DMF 60 5 3
6 [Pd2(dba)3] (5) P(o-CH3C6H4)3 (20),
CuCl (20), K2CO3 (20)
DMF 60 5 91
Table 2. Rapid cross-coupling of methyl iodide and phenyltributylstannane (45).
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ð1Þ
ð2Þ
ð3Þ
ð4Þ
ð5Þ
Thus, CH3I undergoes oxidative addition with a Pd
0 species to afford methyl-PdII iodide (47)
(oxidative addition, Eq. (1)). The PdII complex (47) may directly react with (45) to afford
(methyl)(phenyl)PdII complex (50) (substitution, Eq. (4)); however, the formation of (50) would
be facilitated via Cu complex (48) formed by the Sn/Cu transmetallation (Eq. (2)). K2CO3 reacts
with (n-C4H9)3SnX to form a stable, neutral bis(tributylstannyl)carbonate (49) (Eq. (3)). At the
same time, K2CO3 synergically works with a Cu
I salt to promote the Sn/Cu transmetallation
(Eqs. (2) and (3)) [40]. Finally, (46) is formed by the reductive elimination of PdII complex (50)
(Eq. (5)). The significant effect of tri-o-tolylphosphine is attributed to its considerable bulkiness,
which facilitates the generation of the coordinatively unsaturated Pd0 and PdII intermediates.
The substitution reaction leading to (50) and/or the reductive elimination leading to (46)
requires the formation of the coordinatedly unsaturated tricoordinate PdII complex. DMF
may stabilize such Pd intermediates even at high temperatures. It was very difficult to conduct
the Stille reaction using CH3I as an sp
3-carbon partner [39] until our successful attempt in this
field [3, 4]. Prabhakaran et al. used our reaction conditions for the synthesis of [11C]celecoxib
using a tributyltin substrate after protecting the sulfonamide group [46]. In this context, we
promoted the 11C-labeling without such a protection using the organoborane substrate, yield-
ing higher efficiency for the synthesis (see Section 3.1.5.1.1) [47, 48].
3.1.2. Synthesis of 15R-[11C]TIC methyl ester, a PET probe specific for prostacyclin receptor subtype
(IP2) in the central nervous system
During a study of the design and synthesis of a specific prostaglandin (PG) probe, we
succeeded in developing (15R)-16-m-tolyl-17,18,19,20-tetranorisocarbacyclin (15R–TIC, (15R)-
27b) with specifically high affinity to a novel prostacyclin receptor (IP2) in the central nervous
system (see also Section 2.4.1.2) [25, 49]. The tolyl group in (15R)-27b was considered as a
trigger component to create the PET probe as illustrated in the retrosynthesis of 15R-[11C]TIC
(Scheme 12). The tin precursor ((15R)-53b) was synthesized as shown in Scheme 13 [50]. The
Horner-Emmons reaction of the aldehyde (18) and the phosphonate (51) gave the enone (52) at
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91% yield. The chemoselective 1,2-reduction of the C(15) keto group with NaBH4 in the
presence of CeCl3 gave a 1:1 mixture of the stereoisomeric diols at 87% yield. The C(15)
stereoisomers were separated by conventional silica gel column chromatography, giving
(15S)-53a and (15R)-53b as more and less polar materials, respectively. Thus, we intended to
apply rapid C-methylation conditions to synthesize the 15R-[11C]TIC methyl ester ([11C]-(15R)-
26b) using [11C]CH3I, prepared from [
11C]CO2 according to an established method [51], and
stannane (15R)-53b [50]. However, we found that C-[11C]methylation under radiolabeling
conditions lacked reproducibility for some unknown reasons even after using excess CuI salt.
To overcome this difficulty, we found valuable information for the problem caused by CuI,
which severely reduced the methylation rate of (45) (Table 2, Entry 5). In order to minimize
this inhibitory effect of CuI, we changed the one-pot operation to a two-pot stepwise procedure
 
Scheme 12. Plan for 11C-incorporation: retrosynthesis.
18 +
CH3O
P
OO
CH3O
Sn(n-C4H9)3
COOCH3
HO
Sn(n-C4H9)3
O
less polar, (15R)-53bmore polar, (15S)-53a
2. separation of the C(15) epimers
DME
91%
NaH
1. NaBH4, CeCl3•7H2O, CH3OH, 87%
COOCH3
HO
Sn(n-C4H9)3
OH
COOCH3
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Sn(n-C4H9)3
OH
+
51
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15
Scheme 13. Synthesis of (15R)-16-[3-(tri-n-butylstannyl)phenyl]-17,18,19,20-tetranorisocarbacyclin methyl ester ((15R)-53b).
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for the actual PET probe synthesis (Figure 10) [2]. This procedure consists of independent
syntheses of methylpalladium and a phenyl copper complex at room temperature (RT, 25C),
then a mixing of these species, and heating at an elevated temperature (65C, 5 min). Thus, a
highly sensitive PET probe, [11C]-(15R)-26b, was obtained at up to 85% radiochemical yield
(decay-corrected; total radioactivity of 2–3 GBq; greater than 98% radiochemical and chemical
purities; total synthesis time, 35–40 min (radiochemical purity is a proportion of a magnitude
of desired radiolabeled peak for all the radiolabeled peaks of the isolated product by analytical
radio-HPLC; chemical purity is the proportion of desired peak for all the peaks of the isolated
product by analytical UV-HPLC)), which was then used in rat, monkey, and then human PET
studies.
Here, the principal author, M. Suzuki, became the first volunteer, after the approval of the
Ethics Committee. Thus, [11C]-(15R)-26b was injected into his right arm, which then passed
Figure 10. Synthesis of 15R-[11C]TIC methyl ester ([11C]-(15R)-26b) using a two-pot stepwise procedure.
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through the blood–brain barrier to be hydrolyzed in the brain. The resulting free carboxylic
acid eventually bound to the IP2 receptor distributed throughout various parts of the human
brain (Figure 11, see also Figure 7) [2]. A PET study of the middle cerebral artery occlusion
using a monkey model demonstrated that 15R–TIC has a potent neuroprotective effect against
focal cerebral ischemia as judged by the [15O]O2 consumption and the uptake of [
18F]FDG [52].
The PET studies for rats and humans using the [11C]-(15R)-26b showed that it could be an
useful probe for the in vivo analyses of the MRP2-mediated hepatobiliary transport [53], 17-(3-
[11C]Methylphenyl)-18,19,20-trinor-prostaglandin F2α isopropyl ester ([
11C]-54) [54] targeting
the PGF2 α receptor was also synthesized under similar reaction conditions.
3.1.3. Rapid C-methylation of heteroaryl-substituted stannanes and application to 11C-labeling
There is a great demand to incorporate short-lived 11C-labeled methyl groups into heter-
oaromatic carbon structures because such structures often appear in major drugs and their
promising drug candidates. The rapid methylations of hetero-aromatic ring-substituted
tributylstannanes (55a–i) were carried out [55] by first employing our previous reaction condi-
tions: CH3I/55a–i/[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 (1:40:0.5:2:2:2) in DMF at 60
C for
5 min (conditions A) [55], affording the desired products in low yields (Table 3). An increase in
the phosphine ligand (conditions B) significantly improved the yields of (56b), (56c), and (56i);
however, the conditions were still insufficient in terms of adaptable heteroaromatic structures
(substrate scope). Another CuBr/CsF combination system (conditions C) also provided the
same results as conditions B. Pyridine and the related heteroaromatic compounds still
remained less reactive. Consequently, the problem was solved by replacing DMF with NMP.
Interestingly, the solvent effect though not observed for the CuCl/K2CO3 system, was observed
for the CuBr/CsF system (Table 4, Entry 2), affording 2-methylpyridine (56d) at 81% yield.
Other solvents except amide-type solvents and amine additives were not effective. Thus, the
reaction in NMP at 60–100C for 5 min using CH3I/55a–i/[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF
(1:40:0.5:16:2:5) (conditions D) afforded the methylated products (56a–i) at >80% yields for all
the heteroaromatic compounds listed in Table 3. It should be noted that we did not find the
conditions using a [Pd{P(tert-C4H9)3}2]/CsF system in NMP reported by Fu [56] effective for
methylation (21% yield, Table 4, Entry 2).
2- and 3-[11C]Methylpyridines ([11C]-56d and 56e) were obtained at 88% and 91% radio-HPLC
analytical yields (a percentage of the magnitude of the peak of the desired product for all the
Figure 11. PET imaging in human (left) and monkey (right) brains using (15R)-[11C]TIC-Me ([11C]-(15R)-26b).
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Entry Heteroaryl stannane 55 Methylated compound 56 Yield, %
Aa Ba Ca Da
1
55a 56a
28 75 73 80
2
55b 56b
57 87 91 94
3
55c 56c
52 88 90 94
4
55d 56d
16 67 63 81
5
55e 56e
25 61 66 80
6
55f 56f
79 60 68 87
7
55 g 56 g
3 50 48 87b
8
55 h 56 h
25 72 70 90
9
55i 56i
12 83 75 83
aReaction conditions (molar ratio): A: CH3I/ 55/[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 (1:40:0.5:2:2:2) in DMF at 60
C
for 5 min; B: CH3I/55/[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 (1:40:0.5:16:2:5) in DMF at 60
C for 5 min; C: CH3I/55/
[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:40:0.5:16:2:5) in DMF at 60
C for 5 min; D: CH3I/55/[Pd2(dba)3]/P(o-CH3C6H4)3/
CuBr/CsF (1:40:0.5:16:2:5) in NMP at 60C for 5 min.
bThe reaction was conducted at 100C.
Table 3. General rapid C-methylation on various neutral and basic heteroaromatic rings.
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peaks of radiolabeled compounds appearing in the radio-HPLC chart), respectively, using the
[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:16:2:5) system inNMP at 60
C for 5min (Figure 12) [55].
Synthesis of [11C]H-1152, a PET probe specific for Rho-kinases: H-1152 (60) is known as the most
potent, specific, and membrane-permeable inhibitor of small G protein Rho-associated kinase
(Rho-kinase). A 11C-labeled H-1152 ([11C]-60), as a novel PET probe, for imaging Rho-kinases
was synthesized for the first time based on the Pd0-mediated rapid C-[11C]methylation for
heteroaryl-substituted stannane with a trifluoroacetyl (TFA) protecting group using [11C]CH3I
followed by rapid deprotection of the TFA group [57]. The lithiation of bromide (58) prepared
from (57) by protection with TFA, which is necessary for the subsequent tributylstannylation,
was accomplished in a highly selective manner even in the presence of highly sensitive (to a
nucleophile) TFA amide functional group. We focused on the use of tert-C4H9Li with stronger
electron transfer capability and less nucleophilic character than n-C4H9Li and HMPA, which
can modulate the structure of an organolithium compound by strong coordination. The
CH3I/55d/[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 (1:40:0.5:16:2:2) or CH3I/55d/[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF
(1:40:0.5:16:2:5) at 60C for 5 min.
Entry Solvent Additive, equiv Yield, %
CuCl/K2CO3 CuBr/CsF
1 DMF — 67 65
2 NMP — 66 81 (21)a (39)b
3 DMA — — 69
4 DMI — — 18
5 toluene — — 20
6 THF — — 38
7 DMSO — — 23
8 HMPA — — 34
9 DMF 2,6-lutidine (17) — 19
10 DMF triethylamine (14) — 20
11 DMF DABCO(18) — 6
aFu’s original conditions [56] (molar ratio): CH3I/55d/[Pd{P(tert-C4H9)3}2]/CsF (1:40:1:2).
bFu’s original conditions + CuBr (molar ratio): CH3I/55d/[Pd{P(tert-C4H9)3}2]/CuBr/CsF (1:40:1:2:5).
Table 4. Effect of solvent and additive with increased phosphine and synergic system (CuCl/K2CO3 or CuBr/CsF) on the
rapid coupling of methyl iodide and 2-pyridyltributylstannane (55d) to afford 2-methylpyridine (56d).
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separated ion pair species formed under such HMPA-rich conditions [58], where the excess
HMPA fully coordinate with the lithium cations and thereby reduce the coordination of Li to
the carbonyl functional group, resulted in the loss of the reactivity of nucleophiles for the
carbonyl to perform the stannylation highly selectively. Thus, the treatment of (58) with tert-
C4H9Li (2 equiv) at98
C for 2 h, followed by the continuous addition of HMPA (6 equiv) and
(n-C4H9)3SnCl (1.5 equiv) at 98
C, then warming to RT for 10 h, afforded (59) at 68% yield
(Scheme 14). C-[11C]Methylation using [Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:16:2:5) system
in NMP at 80C for 5 min followed by rapid deprotection using 2 M NaOH at 25–50C for
1 min afforded [11C]-60 at 86% radio-HPLC analytical yield [57]. Isolated radioactivity:
3.8 GBq; radiochemical yield: 63% (decay-corrected); chemical and radiochemical purities:
>99%; total synthesis time: 38 min. This PET probe can be used for the molecular imaging
studies of cardiovascular diseases.
Syntheses of [methyl-11C]thymidine, 40-[methyl-11C]thiothymidine, and [11C]zidovudine ([11C]AZT):
In order to develop a more specific tumor imaging agent than [18F]FDG [59, 60], the imaging
studies were focused on the phosphorylation by thymidine kinase 1 (TK1), whose activity
increases by almost 10-fold during active DNA synthesis and proliferation of cancer [60]. 40-
Thiothymidine (62b), which shows similar biological properties as thymidine (62a) and a
higher stability for the nucleoside cleavage than (62a), underwent 11C-labeling and was used
for tumor imaging in a rat where it exhibited a higher potential as an attractive PET probe than
[18F]FLT [61]. In this context, FMAU and (62b) have so far been labeled by 11C using the 5-
trimethyl and/or tributylstannyl precursors [44]. However, such conditions resulted in lower
efficiency for the reactions of 5-tributylstannyl-20-deoxyuridine (61a) and 5-tributylstannyl-40-
thio-20-deoxyuridine (61b) using [Pd2(dba)3]/P(o-CH3C6H4)3 (1:4) at 130
C for 5 min in DMF,
Figure 12. Syntheses of 2- and 3-[11C]methylpyridines ([11C]-56d and [11C]-56e).
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affording the desired products (62a) and (62b) at 32% and 30% yields, respectively (Table 5,
Entries 1 and 4). We tried to employ our reaction conditions here. The chemo-response of the
thiothymidine precursor was different from the thymidine system [62]. The reaction using the
CH3I/61a/[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:25:1:32:2:5) system including another CuBr/
CsF system, afforded (62a) at quantitative yield (Entry 3). The conditions for (61b) afforded
(62b) at only 40% yield (Table 5, Entry 5). The reaction using five-fold amounts of CuBr/CsF at
80C afforded (62b) at a much higher yield (83%, Entry 6); however, the reaction produced a
large amount of an undesired destannylated product. Considering that the destannylated
product (64) is produced by a proton transfer to the transmetallated Cu intermediate (63) from
(61bCu2) with the enhanced acidity of the NH proton caused by Cu
I coordination to an S atom
(Figure 13), we changed the medium to a much more basic system using a CH3I/61b/
[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 (1:25:1:32:2:5) system at 80
C to afford (62b) in nearly
quantitative yield (98%, Table 5, Entry 7) [62]. Here, K2CO3 would prevent the proton transfer
from (61bCu2) to (63) by forming (65).
Each optimized condition obtained for (61a) and (61b) was successfully used for the syntheses of
the corresponding PET probes using the two-pot procedure (see Section 3.1.2) [62], affording
[11C]-62a and [11C]-62b at 87 and 93% radio-HPLC analytical yields, respectively (Figure 14) [62].
The desired 11C-labeled compounds were isolated by preparative HPLC to afford 45% in 42–59%
isolated radiochemical yields (decay-corrected). The total synthesis time was 42 min in each case
until radiopharmaceutical formulation with the total radioactivity as follows: 3.7–3.8 GBq; chem-
ical purity: ≥98% and radiochemical purity: ≥99.5% sufficient for the human PET study [62].
Scheme 14. Synthesis of [11C]H-1152 ([11C]-60), a PET probe specific for Rho-kinases.
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One of reasons for the low reproducibility of the one-pot reaction for Pd0-mediated rapid
C-[11C]methylation (see Section 3.1.2) using a stannyl precursor is considered to be that the
highly reactive organocopper RdCu (R = phenyl, vinyl, and heteroaromatic) species formed
Figure 13. Assumed equilibration between a stannyl thiothymidine (61b) and a CuI salt.
Entry X P(o-CH3C6H4)3, equiv Cu
I, base
(molar ratio)
Yield, %
60 C 80 C 100C 130C
1 O 4 — 0 — — 32
2 O 32 CuCl, K2CO3 (2:5) 67 85 — —
3 O 32 CuBr, CsF (2:5) 100 — 97 —
4 S 4 — — — — 30
5 S 32 CuBr, CsF (2:5) 40 — — —
6 S 32 CuBr, CsF (10:25) 64 83 — —
7 S 32 CuCl, K2CO3 (2:5) 83 98 — —
Table 5. Synthesis of thymidine (62a) and 40-thiothymidine (62b) by the rapid coupling of methyl iodide and 5-
tributylstannyl-20-deoxyuridine (61a) and 5-tributylstannyl-40-thio-20-deoxyuridine (61b).
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by the Sn/Cu transmetallation induces side reactions such as demetallation and homocoupling
leading to RH and RdR, respectively. In this context, we found that the homocoupling of
organocopper, RdCu, can be greatly suppressed by bubbling [11C]CH3I in the mixture at
lower temperature (20C) followed by heating at 80C for 5 min. Thus, the efficient synthesis
of [11C]-62b was possible by the one-pot method, with much higher (double) isolated total
radioactivity (7.6 GBq) [63]. The novel one-pot procedure was also applied to the 11C-labeling
of AZT (67), known as an anti-HIV and anti-tumor agent. Thus, the 11C-labeling was
conducted for (66) as shown in Figure 15 to give [11C]-67. The isolated [11C]-67 showed a high
radioactivity of 7.0 GBq with a radiochemical purity of >99.5% [63]. In the PET experiment,
[11C]-67 was shown to be accumulated in the C6 tumor with high selectivities (Figure 15) [64].
Figure 14. Synthetic scheme of [methyl–11C]thymidine ([11C]62a) or 40-[methyl–11C]thiothymidine ([11C]62b) (A), and
radio-HPLC analyses of [11C]62a and [11C]62b (B and C, respectively, radioactivity and UV vs. time). The peaks at the
retention times of 7.6 and 7.4 min in B and C are [11C]62a and [11C]62b, respectively. (A) X = O: [Pd2(dba)3]/P(o-
CH3C6H4)3/CuBr/CsF (1:32:2:5).
Figure 15. Synthetic scheme of [11C]zidovudine ([11C]AZT, [11C]-67) and PET imaging of C6 tumor-bearing mice.
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3.1.4. Rapid C-methylation of alkenes (rapid coupling between sp2(vinyl)-sp3 hybridized carbons) and
application to 11C-labeling
In the process of optimizing the rapid C-methylation conditions using 12 types of non-
functional and functional 1-alkenyltributylstannanes (68a–l) (Table 6) as the model com-
pounds, we developed generally applicable conditions, affording the corresponding methyl-
ated compounds (69a–l) at 90% or greater yields [65]. The high efficiency of the reaction: CH3I/
68/[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:40:0.5:2:2:5) is probably due to the use of a bulky
arylphosphine, the synergic effect of the CuI salt and fluoride anions (Eqs. (20) and (6)), which
promotes the Sn/Cu transmetallation by shifting.
CH3I/68a–l/[Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:40:0.5:2:2:5).
Entry 1-Alkenyltributylstannane 68 Yield, % Entry 1-Alkenyltributylstannane 68 Yield, %
1 68a 98 7
68 g
99
2
68b
99 8
68 h
89
(91)a
3
68c
83
(88)a
9
68i
85
(96)a
4
68d
84
(89)a
10
68j
86
(93)a
5
68e
99 11
68 k
95
6
68f
99 12
68 l
84
(91)a
aModified conditions: [Pd2(dba)3]/P(o-CH3C6H4)3/CuBr/CsF (1:8:4:10).
Table 6. Rapid C-methylation on alkenyl structures.
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ð6Þ
the equilibrium. The reactions using the Pd0 complex, [{(pi-allyl)PdCl}2]/3P(tert-C4H9)2(CH3),
(CH3)4NF, 3-Å molecular sieves [66]; or [PdCl2]/2P(tert-C4H9)3, CuI, CsF [67] afforded the
desired products at only the same 2% yields using (68e). The stereoisomerization of the double
bond did not occur at all.
The utility of the reaction was demonstrated by the synthesis of a 11C-labeled partial retinoid
derivative, [11C]-69l, using reaction conditions with CuCl/K2CO3 or CuBr/CsF at 85% radio-
HPLC analytical yields (Figure 16) [65].
3.1.5. Rapid C-methylation of alkynes (rapid coupling between sp-sp3 hybridized carbons) and
application to 11C-labeling
As shown in Table 7, the reaction of tributyl-1-hexynyl-stannane (70) ([CH3I]/[70] = 1:40) using
[Pd{P(C6H5)3}4] for 5 min afforded the desired 2-heptyne (71) at a poor yield (Entry 1) [68]. Our
previous conditions (described in Section 3.1.1), [Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3, were
Figure 16. Synthesis of a 11C-labeled partial stannane of retinoid [11C]-69 l (A) and radio-HPLC analysis (B). Conditions
for (A): [Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 (0.5:2:5:5): 85%.
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also not applicable (Entry 6). Consequently, we found that the bulky and strong σ electron-
donating ligand, P(tert-C4H9)3, facilitates the methylation [68]. The use of fluoride ions such as
CsF or KF was extremely efficient in promoting the reaction. Thus, the reaction in the presence
of [Pd{P(tert-C4H9)3}2] and KF in DMF at 60
C for 5 min afforded (71) at 95% yield (Entry 14)
[68]. The hypervalent stannate (72) is expected to be formed as a reactive species (Eq. (7)). The
reaction was applicable to syntheses of 17β-estradiol and 5-(1-propynyl)-20-deoxyuridine,
which contains several types of functionalized propynyl structures, at 87% and 74% yields [68].
ð7Þ
Synthesis of [11C]iloprost methyl ester: Iloprost (74) is a stable prostacyclin (PGI2) analog specific
for the PGI2 receptor, IP (IP1), in peripheral systems. It is used as a potential therapeutic agent
[69], containing a 1-propynyl moiety on the ω-side chain (see Section 2.4.1.1). The 11C-labeled
iloprost methyl ester ([11C]-74) was synthesized using [11C]CH3I and a stannyl precursor (73)
Entry Pd0 Additives Yield, %
1 [Pd(PPh3)4] — 27
2 [Pd2(dba)3] PPh3 11
3 [Pd2(dba)3] P(2-furyl)3 30
4 [Pd2(dba)3] AsPh3 61
5 [Pd2(dba)3] P(o-CH3C6H4)3 20
6 [Pd2(dba)3] P(o-CH3C6H4)3, CuCl, K2CO3 43
7 [Pd2(dba)3] P(cyclohexyl)3 49
8 [Pd2(dba)3] PCH3(tert-C4H9)2 67
9 [Pd2(dba)3] P CH3(tert-C4H9)2,CsF 10
10 [Pd{P(tert-C4H9)3}2] P(tert-C4H9)3 72
11 [Pd{P(tert-C4H9)3}2] — 81
12 [Pd{P(tert-C4H9)3}2] CuCl, K2CO3 45
13 [Pd{P(tert-C4H9)3}2] CsF 92
14 [Pd{P(tert-C4H9)3}2] KF 95
15 [Pd{P(tert-C4H9)3}2] TBAF 15
Table 7. Pd0-mediated rapid C-methylation using CH3I and an excess amount of tributyl-1-hexynyl-stannane (70).
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at up to 72% radio-HPLC analytical yield under the conditions noted in Table 7, Entry 14
(Figure 17) [2]. Thus, we have synthesized both [11C]iloprost methyl ester ([11C]-74) and 15R-
[11C]TIC methyl ester ([11C]-(15R)-26b) as specific PGI2 receptor ligands of peripheral and
central nervous systems, respectively (Figure 18).
Figure 17. Synthesis of [11C]iloprost methyl ester ([11C]-74).
Figure 18. Specific PET probes for prostacyclin receptors in peripheral and central nervous systems.
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3.1.5.1. Rapid C-methylation using aryl, alkenyl, and alkyl boronic acid esters as coupling substrates
and applications to 11C-labelings
Organoboranes are less toxic than organostannanes. We intended to elaborate the rapid C-
methylation based on Suzuki-Miyaura cross-coupling reaction [70] as a complementary
method to the Stille reaction. The Merck group reported the syntheses of [11C]-46 derivatives
using [11C]CH3I and an excess amount of phenylboronic acid ester in the presence of
[PdCl2(dppf)] and K3PO4 in DMF under microwave heating conditions at high temperatures
[71]. We intended to establish a more efficient and practical method using a Pd0-bulky phos-
phine complex without microwave heating in view of the careful treatment needed for a
radiolabeled compound [72].
3.1.5.1.1. Pd0-Mediated rapid C-methylation of aryl- or alkenylboronic acid ester: Rapid couplings
between sp2(aryl, vinyl)-sp3 hybridized carbons
We set up a reaction using phenylboronic acid pinacol ester (75) ([CH3I]/[75] = 1:40) with a
short reaction time fixed at 5 min [72]. The reaction under general Suzuki-Miyaura cross-
coupling conditions [70] did not give satisfactory results (24–39% yields; Table 8A, Entries 1–3).
Therefore, we used the Pd0 complex coordinated to a bulky phosphine ligand inspired by our
earlier success with Pd0-mediated rapid C-[11C]methylations using organostannanes [40]. The
reaction rate was dramatically accelerated by the tri-o-tolylphosphine Pd complex in DMF in
the presence of K2CO3, K2CO3/H2O, Cs2CO3, or K3PO4 to afford the desired toluenes at 87–
94% yields (Table 8A, Entries 4–7). The rapid coupling reaction of CH3I and (75) probably
proceeds via several steps as follows (Eqs. (1), (8)–(11)) [72]:
Entry. Pd0 complex Ligand (L) Pd0:La Additive Solvent Yield, %
1 [Pd{P(C6H5)3}4] — — K2CO3 1,4-dioxane 39
2 [PdCl2{P(C6H5)3}2] — — K3PO4 DME/H2O 24
3 [PdCl2(dppf)CH2Cl2] — — K3PO4 DME/H2O 28
4 [Pd2(dba)3] P(o-CH3C6H4)3 1:2 K2CO3 DMF 91
5 [Pd2(dba)3] P(o-CH3C6H4)3 1:2 K2CO3 DMF/H2O 94
6 [Pd2(dba)3] P(o-CH3C6H4)3 1:2 Cs2CO3 DMF 92
7 [Pd2(dba)3] P(o-CH3C6H4)3 1:2 K3PO4 DMF 87
aMolar ratio.
Table 8A. An optimization of conditions for rapid cross-coupling of methyl iodide with phenylboronic acid pinacol ester.
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ð1AÞ
ð8Þ
ð9Þ
ð10Þ
ð11Þ
(i) oxidative addition to afford the methyl-PdII iodide (47) (Eq. (1)); (ii) the formation of the
boronate complex (76) (Eq. (8)); (iii) the substitution reaction of (47) with (76) to afford
[PdII(methyl)(phenyl)] complex (50) and unstable borate K+[B(pin)(OZ)(I)]� (77; Z = COOK or
H) (Eq. (9)); (iv) transformation of (77) to the more stable borate, K+[B(pin)(OZ)2]
– (78,
Eq. (10)); (v) the reductive elimination reaction of (50) to afford (46) (Eq. (11)).
The conditions were applicable to various aryl, alkenyl, and heteroaromatic-ring substituted
boronic acid esters (Table 8B) [72]. Thus, such reactions smoothly proceeded under the follow-
ing conditions: CH3I/borane/[Pd2(dba)3]/P(o-CH3C6H4)3/K2CO3 (1:40:0.5:2:2) in DMF at 60
�C
for 5 min, affording the corresponding methylation products at 80–99% yields, in which the E
and Z olefinic stereoisomers afforded the corresponding methylated products with the reten-
tion of stereochemistry. The boronic acid esters containing a more lipophilic ester moiety
showed the same reactivity as the pinacol ester, thus making the purification of the labeled
probe easier [72].
The conditions (Table 8A, Entry 4) were applied to the synthesis of [11C]p-xylene ([11C]-80)
(Figure 19), using pinacol tolylboronate (79) at 96% radio-HPLC analytical yield [72].
Synthesis of [11C]celecoxib and its metabolite, [11C]SC-62807: Celecoxib (82) is a selective cycloox-
ygenase (COX)-2 inhibitor that shows analgesic and anti-inflammatory effects in patients with
rheumatoid arthritis. In humans, celecoxib is extensively metabolized in the liver via succes-
sive two-step oxidation, initially to a hydroxymethyl metabolite (SC-60613), and, on further
oxidation, to a carboxylic acid metabolite (SC-62807, 83). The majority of celecoxib is excreted
into the bile as (83), a substrate of drug transporters for the OATP1B1 and BCRP. [11C]
Celecoxib ([11C]-82) was synthesized at 98% radio-HPLC analytical yield from boronic acid
pinacol ester (81) using [Pd2(dba)3]/P(o-CH3C6H4)3/K2CO3 (1:4:9 in molar ratio) at 65
�C for
4 min in DMF (Figure 20A and B). Radiochemical yield: 63% (decay-corrected) [47]; total
synthesis time: 30 min; radiochemical and chemical purities: >99% and >98%, respectively.
[11C]SC-62807 ([11C]-83) was also synthesized at 87% radio-HPLC analytical yield from puri-
fied [11C]-82 by rapid oxidation using excess KMnO4 under microwave irradiation conditions
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CH3I/boron/[Pd2(dba)3]/P(o-CH3C6H4)3/K2CO3 (1:40:0.5:2:2).
Entry R = arenyl Yield, % Entry R = alkenyl Yield, %
1 4-CH3OC6H4- 98 12 95
2 3-benzyloxyC6H4- 95 13 92
3 4-CH3C6H4- 99
4 4-PhC6H4- 91 14 96
5 4-FC6H4- 93
6 4-CH3OCOC6H4- 96
a 15 86
7 4-NO2C6H4- 99
8 thiophen-2-yl- 92 16 99
9 furan-2-yl- 85
10 pyridine-4-yl- 80 17 99
11 isoquinolin-4-yl- 85
aMixed solvent (DMF:H2O = 9:1) was used.
Table 8B. Rapid cross-coupling of methyl iodide with a wide variety of pinacol arenyl- and alkenylboronates.
Figure 19. Synthetic scheme of 11C-labeled p-xylene ([11C]-80) by rapid C-[11C]methylation using p-tolueneboronic acid
pinacol ester (79) (A), and radio-HPLC chart in the analysis of the reaction mixture (B).
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(Figure 20A and C), giving [11C]-83 at 87% radio-HPLC analytical yield. Radiochemical yield:
55% (decay-corrected); synthesis time: 20 min; radiochemical purity: >99%. PET studies in rats
and metabolite analyses showed that [11C]-83 was rapidly excreted via hepatobiliary excretion
without further metabolism (Figure 20D), and thus has a great potential, as a suitable PET
probe, to investigate the hepatobiliary transport process [48].
Synthesis of 11C-incorporated acromelic acid analog: Acromelic acid A isolated from Clitocybe
acromelalga induces neuropathic pain allodynia. A novel 11C-labeled PET probe, [11C]PSPA-4
Figure 20. Syntheses of [11C]celecoxib ([11C]-82) and [11C]SC-62807 ([11C]-83) (A), radio-HPLC analyses of [11C]-82 (B)
and [11C]-83 (C), and the time profiles of the radio activity of [11C]-83 in the blood (red point), liver (yellow point), kidney
(pink point), bile (blue point), and urinary bladder (light blue point) determined by PET imaging studies and blood
sampling over a 60-min period after administration of [11C]-83 to male Sprague–Dawley rats (D). The peaks at retention
times of 9.6 (in B) and 4.4 min (in C) are [11C]-82 and [11C]-83, respectively. UV absorbance: 254 nm.
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([11C]-85), was synthesized. The probe has been designed as a simpler acromeric acid structure
to prevent the acromelic acid-induced allodynia, and develop novel analgesic drugs and
diagnostics in the treatment of neuropathic pain [73]. Thus, the rapid C-[11C]methylation of
[11C]CH3I and boronic acid pinacol ester precursor (84) by using [Pd2(dba)3], P(o-CH3C6H4)3,
and K2CO3 in DMF followed by rapid deprotection of the TFA-protected amino acid moiety
and hydrolysis of methyl esters in a onepot reaction within 5 min (4 and 1 min each) afforded
[11C]-85 at >99% both radiochemical and chemical purities [73]; radiochemical yield: 34–43%
(decay-corrected); total radioactivity after purification: 5.0–6.0 GBq (Scheme 15); total synthe-
sis time: 30 min.
Synthesis of [11C]all-trans-retinoic acid: Retinoids are a class of chemical compounds including
both naturally occurring dietary vitamin A (retinol) metabolites and their synthetic analogs,
regulating a wide variety of essential biological processes, such as, vertebrate embryonic
morphogenesis and organogenesis, cell growth arrest, differentiation, apoptosis, and homeo-
stasis, and their disorders. All-trans-retinoic acid (ATRA, 87), the most potent biologically
active metabolite of retinol, is a ligand for the retinoic acid receptors (RAR-α, β, and -γ) and
used in the treatment of acute promyelocytic leukemia. [11C]ATRA ([11C]-87) was synthesized
at 25% radiochemical yield (decay-corrected) from boronic acid ester precursor (86) [74] using
[Pd2(dba)3], P(o-CH3C6H4)3, and Na
+ ascorbate (1:4:9) in DMF/H2O at 65
C for 4 min, followed
by basic hydrolysis of the methyl ester (at 65C) or ethyl ester (at 100C) for 2 min; total
radioactivity: 1.5 GBq; radiochemical and chemical purities: >99% and 97%, respectively; total
synthesis time: 35 min (Scheme 16, see also Section 3.3 for [11C]carbonylation).
Synthesis of [11C]dehydropravastatin: The study of transporter functions in the liver is important
for drug development and diagnosis of hepatic diseases associated with a particular trans-
porter dysfunction. Organic anion-transporting polypeptides (OATPs) and multidrug
resistance-associated protein 2 (MRP2) drug transporters play important roles in the uptake
of drugs into the liver and canalicular efflux, respectively [75]. Pravastatin (88) [76] has been
widely used to lower the cholesterol concentration in blood by inhibiting the action of HMG-
CoA reductase in the liver. The uptake of pravastatin into the liver is mediated by the
OATP1B1 transporter; the drug is then excreted into the bile by MRP2 without metabolism.
Therefore, pravastatin would be a good molecular probe for a PET study to track and evaluate
the functions of these two transporters in an in vivo system [77]. We designed 20,30-dehydropra-
vastatin (89) as it has easier synthetic accessibility and is a suitable target for our new synthetic
Scheme 15. Synthesis of 11C-labeled acromelic acid analog [11C]-85.
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methodology. [11C]-89 was synthesized from protected boronate (90) using [Pd2(dba)3], P(o-
CH3C6H4)3, and K2CO3 (1:3:4) at 65
C for 5 min in THF to afford a mixture including the
desired 11C-incorporated compound [77]. Successive treatments with TBAF in THF and an
aqueous NaOH solution, and then the isolation by HPLC afforded [11C]-89 at radiochemical
yield (decay-corrected), 20%; total radioactivity, 1.2 GBq; radiochemical purity, >99%; chemical
purity, 98%; total synthesis time: 34 min. The PET studies on rats showed that [11C]-89 has
great potential to be a suitable PET probe to evaluate the functions of OATPs and MRP2 in
hepatobiliary excretion (Figure 21) [77, 78].
Scheme 16. Synthesis of 11C-labeled all-trans-retinoic acid ([11C]ATRA, [11C]-87).
Figure 21. Color-coded PET images of the abdominal regions of rats after administration of [11C]-89; radioactivity was
identifiable in the liver, kidneys, and localized mainly in the intestine (via the bile excreted into the intestine) and urinary
bladder (via the urine excreted into the urinary bladder). The radioactivity in the organs was modulated after co-
administration with a typical OATP inhibitor or by using MRP2 hereditary-deficient rats.
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3.1.5.1.2. Rapid C-methylation reaction of benzyl or cinnamyl boronic acid ester (rapid coupling of sp3–
sp3 hybridized carbons)
The transition metal-mediated cross-coupling reactions using alkylboronate produce
undesired alkanes or alkenes induced by ligand scrambling or β-elimination reaction [79–81],
causing safety and environmental problems during the synthesis of PET probes. Thus, the
rapid cross-coupling reactions of CH3I with excess benzyl- and cinnamylboronic acid pinacol
ester lacking hydrogen on neighboring sp3-carbon were studied [82]. We particularly focused
on using a combination of bulky triaryl- or trialkylphosphines/carbonate or fluoride as the
base in DMF, in accordance with our previous studies (Table 9). Thus, the reactions using
CH3I/91/[Pd{P(tert-C4H9)3}2]/CsF (1:40:1:10) in 90:10 DMF/H2O (v/v) at 80
C for 5 min and
CH3I/91/[Pd2(dba)3]/P(o-CH3C6H4)3/K2CO3 (1:40:0.5:2:2) in 90:10 DMF/H2O (v/v) at 120
C for
5 min afforded ethylbenzene (92) at 88% and 43% yields, respectively, as the optimized
conditions for the use of the corresponding bulky phosphines (Table 9, Entries 7 and 2,
respectively) [82]. Interestingly, the yield obtained using the former reaction conditions was
temperature dependent, resulting in a bell-shaped curve (Figure 22). The use of an excess
amount of substrate (91) (200 equiv. for methyl iodide) gave positive results for the former
reaction leading to quantitative yield of the product (Table 9, Entry 7), thus agreeing well with
an actual PET study using largely excess trapping substrate (see Section 3).
CH3I/91/Pd
0/ligand/Base (1:40:1:2:2–10).
Entry Pd0a Base Solvent Yield, %
(equiv) 60 C 80 C 100C 120C
1 A K2CO3 (2) DMF 6 — 18 —
2 A K2CO3 (2) DMF/H2O 20 32 (27)
c 39 (45)c 43 (37)c
3 A CsF (10) DMF/H2O 34 47 (36)
c 36 40
4 B K2CO3 (2) DMF/H2O — 40 (70)
c 32 25
5 B CsF (10) DMF 42 58 — —
6 B KF (10) DMF/H2O — 62 61 —
7 B CsF (10) DMF/H2O 54 88 (100)
c 62 6–59
8 Bb CsF (10) DMF/H2O — 61 — —
aPd0/ligand:A, [Pd2(dba)3]/P(o-CH3C6H5)3; B, [Pd{P(tert-C4H9)3}2].
bExcess P(tert-C4H9)3 (16 equiv).
cReaction using a five-fold excess of boronate substrate (200 equiv).
Table 9. Rapid cross-coupling of methyl iodide and benzylboronic acid pinacol ester (91).
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The use of a bulky trialkylphosphine (cone angle = 182 for P(tert-C4H9)3) with its much higher
basicity (pKa = 11.4 for P(tert-C4H9)3) [83] relative to an arylphosphine (pKa = 3.8 for P(o-
CH3C6H4)3) [83] could be important to promote the rapid C-methylation. As shown in
Figure 23, P(tert-C4H9)3 with a strong σ electron-donating ability can generate a coordinatively
unsaturated tricoordinated PdII complex, CH3Pd
II(L)I (94), by oxidative addition (Eq. (12)),
which could be in equilibrium with the highly polarized (or ionized) Pd(II) complex
[CH3Pd
II(L)]+I� (940) owing to strong electron donation from the phosphine ligand. The
resulting complex (94) (or 940) readily undergoes an/a iodide/benzyl group exchange upon
reaction with fluoro benzylboronate (95) formed by coordination of fluoride to boron (Eqs. (13)
and (14)), affording a tricoordinated complex (96) and Cs salt (97). The former undergoes
Figure 22. The yields of ethylbenzene by the reactions at various temperatures using CH3I/91/[Pd2(dba)3]/P(o-
CH3C6H4)3/K2CO3 (1:40:0.5:2:2) (white square) and CH3I/91/[Pd{P(tert-C4H9)3}2]/CsF (1:40:1:10) (black square) in 90:10
DMF/H2O (v/v) for 5 min.
Figure 23. Assumed mechanism for the rapid cross-coupling of methyl iodide and benzylboronic acid pinacol ester (91)
using [Pd{P(tert-C4H9)3}2]/CsF/DMF/H2O.
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reductive elimination (Eq. (15)) to afford (92). Unsaturated tricoordinated PdII complex (96)
could be directly responsible for the reductive elimination.
Optimized reaction conditions were applied to various types of benzyl- and cinnamylboronic
acid pinacol esters, in which electron-donating groups such as p-methoxy, 3,4-dimethoxy, p-
amide, and p-methyl groups or electron-withdrawing groups such as p-chloro, p-fluoro, m-
ethyl ester, and m-trifluoromethyl groups are substituted on the phenyl rings, resulting in 80–
100% yields (Table 10, Entries 4, 5, 7, 9, 10, and 12–14), while the boronic acid esters possessing
o-fluoro or p-trifluoro substituents on the phenyl ring were less reactive (Table 10, Entries 8
and 11) [82].
The utility of a rapid reaction was demonstrated by reacting [11C]CH3I and boronic acid ester
(98c) in the presence of [Pd{P(tert-C4H9)3}2]/CsF (1:10) in 90:10 DMF/H2O (v/v) at 90
C for
5 min to afford N-(4-[11C]ethylphenyl)propionamide ([11C]-99c) in 90% radio-HPLC analytical
yield (Figure 24A and B). Radiochemical yield (decay-corrected): 49%; total radioactivity:
5.9 GBq; radiochemical purity: >99%; chemical purity: 95%; total synthesis time: 32 min [82].
Here, we compared the effects of TlOH and conventional bases, K2CO3 and CsF, for the Pd
0-
mediated rapid cross-coupling based on the use of CH3I with organoboranes (Table 11) [84]. It
should be noted that the rapid C-methylation between CH3I and organoborane reagents such
as phenyl-(75), (Z)-4-benzyloxy-2-butenyl-(100), and benzylboronic acid pinacol esters (91) did
not proceed at all for 5 min under the reported conditions: CH3I/borane/[Pd{P(C6H5)3}4]/TlOH
[85] (1:40:1:3) in THF/H2O at 25
C. Even the use of bulky phosphines at elevated temperatures
gave much lower yield than our findings. Thus, it was concluded that the use of TlOH is not
applicable to the cross-coupling reaction of CH3I and various types of organoborons sub-
strates, reconfirming that the use of the milder and non-toxic bases, K2CO3 or CsF, are most
appropriate for rapid C-[11C]methylation [84].
3.2. Rapid C-[18F]fluoromethylation
C-[18F]Fluoromethylation using [18F]FCH2Br or [
18F]FCH2I is related to the C-[
11C]methylation
described in Section 3.1. The advantages of 18F–labeling are as follows: (1) longer in vivo
monitoring as compared to 11C, (2) delivery of 18F–labeled probes to distant PET centers and
clinics, (3) the possible use of multi-reactions after labeling, and (4) the possible use in click
chemistry as a prosthetic group for the labeling of peptides, nucleic acids, sugars, etc.
According to the reaction conditions established using FCH2I [72, 86], we set up a reaction
using ca. 0.5 GBq of [18F]FCH2X (X = Br or I) and a 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzoic acid methyl ester (101) (Figure 25). The labeling using [18F]FCH2I and (101) in the
presence of [Pd2(dba)3]/P(o-CH3C6H4)3 (1:6) and K2CO3 in DMF for 5 min at 65
C afforded the
desired p-([18F]fluoromethyl)benzoic acid methyl ester ([18F]-102) at 23% radio-HPLC analyti-
cal yield. After a broader investigation, we concluded that the C-[18F]fluoromethylation using
[18F]FCH2Br would be more practical than that using [
18F]FCH2I owing to the instability of the
latter under light-exposed conditions. Thus, the reaction at 120C for 15 min in DMPU/H2O
(9:1) afforded [18F]-102 at 60–80% yields [86]. The 15-min reaction thus obtained agrees with
the requirements of 18F–incorporated PET-probe synthesis because of the longer half-life
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Entry Boronic acid ester Yield, %
60 C 70C 80 C 100C 120C
1
98a
98 — 100 — —
2
98b
77 — 80 — 81
3
98c
91 — 100 — —
4
98d
65 — 91 — —
5
98e
— 75 72 — —
6
98f
80 — 84 — 100
7
98 g
— — 82 — 68
8
98 h
6 — 39 34 35
9
98i
69 — 98 — —
10
98j
87 — 91 — —
11
98 k
— — 19 — 21
12
98 l
— — 43 100 33
13
98 m
30 37 87 59 58
14 98n — — 100 — —
Table 10. Rapid cross-couplings of methyl iodide and benzyl-(98a–98d, 98f–98 k) and cinnamylboronic acid pinacol
esters (98 l–98 m), benzylboronic acid neopentyl glycol ester (98e), and trimethylboroxine (98n) and the corresponding
coupling products (99a–n). Reaction under the conditions of CH3I/98/[Pd{P(tert-C4H9)3}2]/CsF (1:40:1:10) in 90:10 DMF/
H2O (v/v) for 5 min.
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(109.8 min) of the 18F radionuclide compared to 11C (20.4 min) [86]. The rapid reaction proce-
dure afforded 6-([18F]fluoromethyl)quinoline ([18F]-103) at 69% radio-HPLC analytical yield.
Moreover, [18F]fluoromethylated compounds [18F]-104 and [18F]-105were obtained at 45% and
40% radio-HPLC analytical yields [86]. The corresponding acid of p-[18F]fluoromethyl benzo-
ate [18F]-102 could be used as a prosthetic group for 18F–labeled biomarkers with higher
molecular weights such as oligonucleotides, peptides, and proteins.
3.3. Rapid C-[11C]carbonylation under ambient temperature and atmospheric pressure
using conventional helium gas as the [11C]CO carrier
The low solubility of CO in most common solvents has hampered the Pd0-mediated rapid
cross-coupling reaction. Therefore, most of such reactions have been conducted with the use of
special equipment such as high-pressure vessels to facilitate the incorporation of [11C]CO into
the reaction [87]. Chemical [11C]CO fixation techniques have recently been developed as an
alternative with the aim of increasing the concentration of [11C]CO in solution [88]. Pd0-
mediated [11C]carbonylation has enabled the execution of the reaction under atmospheric
pressure using xenon as a carrier gas, an aryl iodide as a substrate, and an amine and alcohol
as trapping nucleophiles for the synthesis of 11C-incorporated amide, urea, and carbamates
[89]. Yamamoto et al. elaborated the methoxycarbonylation of an arylboronic acid or esters
(2,2-dimethylpropane-1,3-diol ester and pinacol ester), which proceeds under atmospheric
pressure at RT for 3–20 hrs, using a catalytic amount of PdII acetate/triphenylphoshine [Pd
(OAc)2]/PPh3 in the presence of p-benzoquinone (pbq) in CH3OH, represented by the follow-
ing mechanism [90]: (1) the transmetalation of the aryl group from boron to palladium
(Eq. (16)); then, insertion of CO into the Pd-C(sp2) bond (Eq. (17)); (3) reaction with alcohol to
Figure 24. Synthesis of N-(4-[11C]ethylphenyl) propionamide ([11C]-99c) (A) and radio-HPLC analysis (B).
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give a desired product (Eq. (18)); (4) oxidation of the Pd(0) species with pbq to give Pd(II)
species, establishing a catalytic cycle (Eq. (19)).
ð16Þ
ð17Þ
ð18Þ
ð19Þ
Entry Boronic acid ester Pd0/ligand Base Solvent Yield, %
25�C 60 �C 80 �C
1
75
[Pd(PPh3)4] TlOH THF/H2O 0 39 —
2 [Pd2(dba)3]
/P(o-CH3C6H4)3
TlOH THF/H2O 60 65 —
3 [Pd2(dba)3]
/P(o-CH3C6H4)3
KOH THF/H2O — 93 —
4 [Pd2(dba)3]
/P(o-CH3C6H4)3
K2CO3 DMF/H2O — 94 —
5
100
[Pd(PPh3)4] TlOH THF/H2O 0 38 —
6 [Pd2(dba)3]
/P(o-CH3C6H4)3
TlOH THF/H2O 26 64 —
7 [Pd2(dba)3]
/P(o-CH3C6H4)3
KOH THF/H2O — 69 —
8 [Pd2(dba)3]
/P(o-CH3C6H4)3
K2CO3 DMF/H2O — 95 —
9
91
[Pd(PPh3)4] TlOH THF/H2O 0 — 14
10 [Pd2(dba)3]
/P(o-CH3C6H4)3
TlOH DMF/H2O — 48 41
11 [Pd2(dba)3]
/P(o-CH3C6H4)3
KOH DMF/H2O — 64 78
12 [Pd2(dba)3]
/P(o-CH3C6H4)3
CsF DMF/H2O — 54 88
Table 11. Effects of bases for rapid trapping of methyl iodide with an excess amount of various boronic acid esters: focus
on the use of TlOH.
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Our interest had been focused on the [11C]CO fixation method and Yamamoto’s methoxycar-
bonylation conditions. The synthesis of [11C]benzoic acid methyl ester ([11C]-107) was
conducted using the reaction of phenylboronic acid 2,2-dimethlpropane-1,3-diol ester (106)
and [11C]CO as a model reaction (Table 12) [91]. However, such conditions gave the desired
product at lesser than 3% decay-corrected radiochemical yield (RCY) at RT for 5 min (Entries
1–7). Here, we have surprisingly found that rapid methoxy[11C]carbonylation can be facilitated
simply by adding DMF in these conditions at RT for 5 min, giving the product [11C]-107 at 25%
RCY (Entry 8). DMSO or THF were ineffective for this purpose. The improved reaction
conditions (the use of a twofold excess of the solvent and reagents and the 11CO trapping at
lower temperature (15C)) were highly favorable to give [11C]-107 (66% RCY, Entry 9) and
[11C]methyl 4-((5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl)benzoate ([11C]-
108) (65% RCY). One-pot synthesis of [11C]carboxylic acid was also established by the combi-
nation of [11C]carbomethoxylation and rapid hydrolysis (80C, 2 min) with aqueous KOH [91].
Artificial retinoid Am80 (Tamibarotene, 110) is an active agent for acute promyelocytic leuke-
mia (APL) patients who have relapsed from ATRA-induced complete remission. It binds
tightly to RAR-α and does not bind to the RAR-γ receptor (see also Section 3.1.5.1.1). The
above improved conditions were applied to the synthesis of [11C]Am80 ([11C]-110) (Scheme
17) [91]. The synthesis was conducted in a one-pot manner without isolation of [11C]-108. Thus,
after methoxy[11C]carbonylation of boronate precursor (109), [11C]-108 underwent rapid
hydrolysis with aqueous KOH at 80C over 2 min to afford the desired acid, [11C]-110, at 48%
RCY based on [11C]COwith 99% radiochemical purity. The total synthesis time for formulation
of [11C]-110 was 36 min. The isolated radioactivity was 1.4 GBq, and the molar activity was
44 GBq/μmol. This new method is also used to achieve the direct syntheses of [11C]aspirin
([11C]-111) using water or tetramethylammonium hydroxide as the hydroxyl source and [11C]
salicylamide ([11C]-112) and [11C]nicotinamide ([11C]-113) with an aqueous ammonia solution
as the nucleophile instead of CH3OH in DMF [92]. This simple [
11C]carbonylation method,
Figure 25. Rapid C-[18F]fluoromethylation of an arylboronic acid pinacol ester (101) with [18F]FCH2X (X = I or Br).
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proceeding at ambient temperature and under atmospheric pressure using conventional helium
gas as a [11C]CO carrier, if successful, should be highly attractive to organic chemists who desire
to synthesize [11C]carbonyl compounds such as 11C-labeled amides, ureas, isocyanates, oxazoles,
and carbamates directly. Another approach to perform [11C]carbonylation of aryl halides and
triflates at atmospheric pressure is reported by Dahl et al. [93], using a hindered phosphine
ligand, xantphos, in combination with palladium(pi-cinnamyl) chloride dimer. Recently, Ander-
sen et al. reported that the isolation of xantphos ligated palladium-aryl oxidative addition
complexes, whose generation generally seems the rate determining step, and [11C]carbonylation
Entry Conditions Solvent Trap. Temp. Reaction Temp. RCY, %
1 1. CuCl, K[Tp*], THF;
2. [Pd(PPh3)4], PPh3
THF-CH3OH-DMF (10:1:4) RT 100
C <1
2 1. CuCl, K[Tp*], THF;
2. [Pd(OAc)2], P(o-tolyl)3
THF-CH3OH-DMF (10:1:4) RT 100
C <1
3 1. CuCl, K[Tp*], THF;
2. [Pd(PPh3)4], PPh3
THF-CH3OH-DMF (10:1:4) RT RT <1
4 1. CuCl, K[Tp*], THF;
2. [Pd(OAc)2], PPh3, pbq
THF-CH3OH-DMF (10:1:4) RT RT 3
5 [Pd(OAc)2], PPh3, pbq CH3OH RT RT 2
6 [Pd(OAc)2], PPh3, pbq CH3OH-DMSO (1:1) RT RT <1
7 [Pd(OAc)2], PPh3, pbq CH3OH-THF (1:1) RT RT <1
8 [Pd(OAc)2], PPh3, pbq CH3OH-DMF (1:1) RT RT 25
9 [Pd(OAc)2], PPh3, pbq CH3OH-DMF (1:1) 15
C RT 26, 66a
10 [Pd(OAc)2], PPh3 CH3OH-DMF (1:1) 15
C RT 20
11 [Pd(OAc)2], PPh3, CsF CH3OH-DMF (1:1) 15
C RT <5
[Pd2(dba)3], P(o-tolyl)3 CH3OH-DMF (1:1) 15
C RT 4
aTwo-fold excess amounts of solvents and reagents were used.
Table 12. Examination of methoxy[11C]carbonylation reaction.
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with [11C]CO under low pressure have been successfully accomplished to give [11C]raclopride
and [11C]olaparib with excellent radiochemical purity and yield [93]. Rahman et al. reported
nickel-mediated [11C]aminocarbonylation of non-activated alkyl iodides containing β-hydrogen
using low concentrations of [11C]CO in the nonpolar protic solvent tert-butyl alcohol [94]. See
also recent reviews for rapid C-[11C]carbonylation [95].
3.3.1. Rapid C-[11C]carboxylation under ambient temperature and atmospheric pressure
Transition-metal-mediated rapid [11C]carboxylation using [11C]CO2 and organoboronate as a
stable metalloid substrate is favorable for 11C-labeling of carboxyl groups. Pike et al. reported
CuI-mediated rapid [11C]carboxylation in the presence of KF/kryptofix 2.2.2 [96]. Alternatively,
we found that the use of acetone is more effective for [11C]CO2 trapping at temperature ranging
Scheme 17. One-pot synthesis of [11C]Am80 ([11C]-110).
Scheme 18. RhI-mediated rapid [11C]carboxylation using [11C]CO2 and organoboronate.
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from 78 to 98C than the use of molecular sieves as absorbent materials. Consequently, [11C]
carboxylation was promoted at atmospheric pressure with a short reaction time of 3–5 min using
RhI catalyst (Scheme 18). The desired [11C]benzoic acid ([11C]-114) was obtained with moderate
radioactivity (2–3 GBq) at 38–57% DCY using approximately 15 GBq of [11C]CO2 [97].
3.4. Other opportunities for rapid 11C-labeling: Synthesis of [11C]NSAIDs and their esters
by rapid C-methylation of enolates
In order to perform the in vivomolecular imaging of cyclooxygenases (COXs), well-known as the
key enzymes in prostaglandin biosynthesis, we intended to develop a novel method to rapidly
incorporate a 11C radionuclide into various 2-arenylpropionic acids that have a common methyl-
ated structure, particularly abundant among nonsteroidal anti-inflammatory drugs (NSAIDs).
Consequently, we elaborated the rapid 11C-labeling using the reaction of [11C]CH3I and an enolate
intermediate generated from the corresponding ester under basic conditions, followed by one-pot
hydrolysis to convert it into the 11C-incorporated acid as [11C]NSAID (Figure26A) [98].Methoxy 2-
arenylpropionate (115) is much less polar due to the increase in hydrophobicity of an introduced
methyl groupand the lesshyperconjugation between theCdHσbondof the benzylic position and
C]Oπ*, which is also possible for the LUMO (π*) of a phenylmoiety, allowing easy separation of
the desired 11C-labeled product from the demethylated compound. This method is quite general
and utilized for the syntheses of the following six PET probes of NSAIDs: [11C]ibuprofen ([11C]-
122), [11C]naproxen ([11C]-123), [11C]flurbiprofen ([11C]-124), [11C]fenoprofen ([11C]-125), [11C]
ketoprofen ([11C]-126), [11C]loxoprofen ([11C]-127), and their corresponding esters as racemates
([11C]-116–121), with sufficient radioactivity (1.7–5.5 GBq) for animal and human PETstudies. The
isolated radiochemical yields (decay-corrected) based on [11C]CH3I of [
11C]-116–127were 26–76%.
Notably, we found that methyl esters were particularly useful as pro-radioprobes for the study of
neuroinflammation in the brain. The microPET studies of rats with lipopolysaccharide (LPS)-
induced brain inflammation clearly showed that the radioactivity of the PET probes, [11C]
ketoprofen methyl ester ([11C]-120), and [11C]ketoprofen ([11C]-126) specifically accumulated in
the inflamed region (Figure 26B), giving the first successful example of the in vivo molecular
imaging of neuroinflammation by noninvasive PET technology. A metabolite analysis of the
rat brain revealed that the intravenously administrated methyl ester was initially taken up in
the brain and then underwent hydrolysis to form a pharmacologically active form of the
corresponding acids. Hence, we succeeded in the general 11C-labeling of 2-arenylpropionic acids
and theirmethyl esters asPETprobes ofNSAIDs to construct a potentially useful PET-probe library
for the in vivo imaging of inflammation involved in the COX expression [99]. The aforementioned
racemic NSAD methyl ester is readily separated by a chiral column to give optically pure com-
pounds among which S-enantiomer of [11C]ketoprofen methyl ester ((S)-[11C]-120) was found to
be a highly selective PET probe for COX-1. Studies using APP-Tg mice demonstrated that
(S)-[11C]-126 detected COX-1 in activated microglia that are associated with amyloid plague
progression, suggesting the involvement of COX-1 in the neuro-inflammation process of
Alzheimer’s disease [99]. [11C]Ketoprofen methyl ester has been used for human whole body
bio-distribution for imaging of neuroinflammation [100]. Tetrabutylammonium fluoride
(TBAF) was also effective to promote the rapid [11C]methylation of the enolate in THF as found
in our and relative groups [101].
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C]
Figure 26. Syntheses of 11C-labeled 2-arylpropionoc acids and their esters (A), and PET images of [11C]ketoprofen methyl
ester ([11C]-120, left panel) and [11C]ketoprofen ([11C]-126, right panel) in rat brain inflammation induced by lipopolysac-
charide injection into the left striatum (B). Left PET image shows high accumulation in the area of inflammation,
indicating that the methyl ester penetrated the blood–brain barrier and underwent hydrolysis in the brain to produce
carboxylic acid as a pharmacologically active form, eventually accumulating in the inflammation area.
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4. Conclusions
PG synthesis: Organometallic techniques opened a direct way to PGs. The one-pot three-
component coupling comprising the construction of the whole PG C20-framework by the
combination of the organocopper or organozincate conjugate addition of the ω-side chain to
(4R)-4-hydroxy-2-cyclopentenone and selective monoalkylation with the α-side chain unit was
realized by the addition of 1 equiv of (C6H5)3SnCl or (CH3)2Zn and excess HMPA for the first
time by our group. The use of acetylenic halide as an α-side chain led to the 5,6-didehydro-PGE2
derivative, which served as the common intermediate for general synthesis of natural PGs.
Combination of a controlled radical reaction, photochemical process, and organometallic and
organosilicon chemistry allowed the synthesis of isocarbacyclin, a stable prostacyclin analog.
15S-APNICwith an azidophenyl group as a photoreactive functionwas also synthesized; it has a
high affinity to the prostacyclin receptor protein in mastocytoma P-815 cells (IC50 = 3 nM). A
protein of approximately 45 kDa was labeled by photolysis using (15S)-[3H]APNIC incubated
with membranes of porcine platelets including a PGI2 receptor. Likely, 15R-TIC with a tolyl
group in ω-side chain was synthesized from the same aldehyde intermediate, which selectively
bound to a novel PGI2 receptor subtype, IP2, expressed in the CNS (IC50 = 32 nM). The length of
the ω-side chain and the position of the methyl substituent on the aromatic ring strongly
influenced the binding characteristics. 15-deoxy-TIC lacking a hydroxy group at C(15) showed
ten-fold higher affinity for the IP2. The green synthesis of the key intermediate, 5,6-didehydro-
PGE2 derivative for general synthesis of natural PGs described was achieved ultimately by
efficient one-pot three-component coupling consisting of organozincate conjugate addition
followed by the enolate trapping with an organic triflate using stoichiometric amounts of three-
components (enone and two ω- and α-side chains with nearly 1:1:1 ratio) without HMPA and
heavy metals. The intermediates corresponding to the syntheses of 15R–TIC and 15-deoxy-TIC,
respectively, were also synthesized by similar protocols.
PET probe synthesis: A groundbreaking methodology based on the use of advanced chemistry was
introduced for the synthesis of short-lived 11C-incorporated PET probes. First, a general method
for the rapid cross-coupling reaction of methyl iodide with phenyltributylstannane (Stille-type
rapid cross-coupling reaction) was established, producing a methylated product at high yield in
the presence of a bulky tri-o-tolylphosphine-bound coordinatively unsaturated Pd0 complex, a CuI
salt, and K2CO3 in DMF. The two salts work synergically to promote the Sn/Cu transmetallation.
The reaction was efficiently used for the synthesis of the 15R-[11C]TICmethyl ester as a PET probe.
The rapid C-methylation was expanded to other types of rapid C-methylations including the
methylations of heteroaromatic compounds and alkenes by using other CuI/CsF synergy as well
as alkynes and choosing a bulky trialkylphosphine/KF or CsF in the absence of CuI salt. The choice
of NMP, as a solvent, is important in the methylation of heteoaromatic compounds. These rapid
reactions could afford various radiolabeled biologically and clinically important molecules.
To meet further demands for efficient labeling methods in PET, a rapid C-methylation was
established using methyl iodide and organoboranes (Suzuki-Miyaura type rapid cross-coupling
reaction), complementary to organostannanes. The reactions using phenyl, heteroaromatic,
and alkenylborane substrates proceeded at high yields in the presence of [Pd2(dba)3], tri-o-
tolylphosphine, and K2CO3 or K2CO3/H2O, while the rapid cross-coupling reactions of sp
3- and
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sp3-hybridized carbons were possible using bulky tri-tert-butylphosphine-bound coordinatively
unsaturated Pd0 complex and CsF in 90:10 DMF/H2O (v/v) at high yields. The incorporation of
rather longer half-life 18F radionuclides into organic structures was also possible by rapid C-[18F]
fluoromethylation using [18F]FCH2X (X = I or Br) and organoboranes. It was also found that the
conditions reported so far by other researchers using the Stille and Suzuki-Miyaura type cross-
coupling reactions using organostannane and borane compounds (even using TlOH as base) were
totally much less effective than ours. The rapid C-[11C]methylation conditions would be useful for
[11C]CH3I prepared by gas-phase reaction of [
11C]CH4 and iodine [102, 103], providing the labeled
compound with higher specific activity. Rapid C-[11C]carbonylation was also established by the
PdII-mediated reaction of [11C]CO and common arylboronate at ambient temperature under
atmospheric pressure using conventional helium carrier gas. Likely, the rapid C-[11C]carboxylation
under atmospheric pressure was promoted by the use of RhI catalyst.
Recently, we have further applied our rapid C-methylation to the synthesis of 10-O-p-[11C]
methylbenzyl ginkgolide B (128) andO6-[(3-[11C]methyl)benzyl]guanine (129) as newly designed
PET probes for the study of brain permeability of ginkgolides in monkeys and rats [104] and for
conducting the imaging of DNA repair protein O6-methylguanine-DNA methyltransferase in
glioblastoma [105], respectively. Further, novel rapid C-methylation methodology have also been
employed for the syntheses of novel PET probes by us and our collaborators, such as 40-[11C]
methylflavone ([11C]-130) [106], [11C]cetrozole (11C-incorporated aromatase inhibitor) ([11C]-131)
[107], [11C]thiamine ([11C]-132) [108], [11C]fursultiamine ([11C]-133) [108], and 11C-labeled GN8
([11C]-134) for prion imaging [109]. Furthermore, our new methods have widely been applied
by other research groups to synthesize 11C-labeled PET probes such as a serotonin transpor-
ter inhibitor, [11C]MADAM ([11C]-135) [110], [11C]toluene ([11C]-46) [111]; a central nicotinic
acetylcholine inhibitor, [11C]5MA ([11C]-136) [112]; a serotonin reuptake inhibitor, citalopram
analog, [5-methyl-11C]{3-[1-(4-fluorophenyl)-5-methyl-1,3-dihydroisobenzofuran-1-yl]- propyl}-
dimethylamine ([11C]-137) [43]; an adrenergic neurotransmitter, 4-[11C]methylmetaraminol
([11C]-138) [113]; a COX-2 selective inhibitor and prescription drug, [11C]celecoxib ([11C]-82) [46];
sigma1 receptor ligand, (+)-p-[
11C]methylvesamicol ([11C]-139) [114]; vesicular acetylcholine
transporter ligand, (�)-[11C]OMV ([11C]-140) [115]; an NK-3 receptor antagonist, [11C]SB 222200
([11C]-141) [116]; a norepinephrine transporter ligand, a reboxetin analog, [11C]MENET ([11C]-
142a) and [11C]MESNET ([11C]-142b) [117]; a derivative of the selective α7 nicotinic acetylcholine
receptor partial agonist, [11C]CHIBA-1001 ([11C]-143) [118]; an I2-imidazoline receptor selective
ligand, [11C]metrazoline ([11C]-144) [119], [11C]TEIMD ([11C]-145) [119], and [11C]FTIMD ([11C]-
146) [119]; a metabotropic glutamate 1 receptor ligand, N-[4-[6-(isopropylamino)pyrimidin-4-yl]-
1,3-thizol-2-yl]-N-methyl-4-[11C]methylbenzamide ([11C]-147) [120]; a selective 5-HT7 antagonist,
[11C]CIMBI-712 ([11C]-148) [121]; vesicular acetylcholine transporter ligand, [11C](R,R)HAPT
([11C]-149) [122]; imaging of presynaptic dopamine synthesis, [11C]6MemTyr ([11C]-150) [123];
imaging of metabotropic glutamate receptor subtype 4, [11C]ADX88178 ([11C]-151) [124], etc.
5. Perspectives
The straightforward construction of the main skeleton of a molecule by assembling multi-
components (convergent synthesis) is an ideal synthetic methodology in organic synthesis in
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ely view of its directness and high synthetic flexibility. Such a synthetic approach requires readily
accessible optically active components and highly selective asymmetric or diastereomeric CdC
bond forming reactions. Three-component PG synthesis established in this study meets both
requirements [15]. It is possible to expand the short-step synthesis method with high flexibility to
the synthesis of a variety of analogs with improved biological activities and new significant
biofunctions. In fact, it was well demonstrated that stable PG analogs thus created served not
only to elucidate the target molecule connected with the mechanism of biofunction but also to
discover new targets with novel biofunctions such as the IP2 receptor in the brain. The green
process has a great potential from practical and environmental points of view, and therefore, this
convergent process would also be applied to a wide variety of enone structures to supply
important organic frameworks for the syntheses of molecules with biological significance.
PET molecular imaging is the only non-invasive method for elucidating the entire-body phar-
macokinetics of molecules in humans with high sensitivity and accurate quantification. This
technique could be adaptable to the screening of drug candidates by introducing human
microdosing studies at an early stage of the drug development (phase 0 by microdose admin-
istration under regulated guidance) [125] to decrease the large drop out of drug candidates
(>90%, called “the Death Valley”) during clinical trials (phases I–III), eventually saving huge
investment and time for drug development (Figure 27); thus, revolutionizing drug develop-
ment process and disease diagnosis. Furthermore, the use of a defined PET biomarker would
be effective for the evaluation of drug efficacy after long-termed administration of a drug
candidate particularly for dementia patients such as those suffering from Alzheimer’s disease.
Thus, novel chemical probes with a short-lived radioisotope would serve as efficient tools to
particularly advance a study in human and environmental sciences in terms of ultra high
sensitivity and safety due to less radiation exposure.
Our new methods are also applicable to other C, H, and F isotopes, such as 13CH3,
14CH3, CD3,
and CH2
19F, allowing the synthesis of a molecular probe for accelerator mass spectrometry
(AMS), MRI, etc.
An interdisciplinary associated diverse study among chemistry, biology, and medicine has
increasingly become more important in the field of chemical biology and molecular imaging
particularly relating to drug development and disease diagnosis.
Chemical tools covering a broad range of design, synthesis, and the labeling of significant
biological and pharmaceutical molecules could play a central role in an interdisciplinary
research area such as bio-, medical-, life (live)-, and environmental sciences.
Figure 27. The use of PET toward revolutionizing drug discovery processes.
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